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Abstract 
Epigenetics refers to heritable changes of phenotype or gene expression 
without the modification of DNA sequence. DNA methylation, a prominent 
epigenetic marks, is associated with gene expression, X chromosome inactivation, 
gene imprinting and developmental process. DNA methylation occurs by DNA 
methyltransferase to add methyl group at the 5th carbon of a cytosine to produce 5-
methylcytosine (5mC), which is achieved by a similar mechanism in both the plants 
and animals. However, DNA demethylation pathways are fundamentally different in 
plant and animal. In animals, DNA demethylation is achieved by several enzymatic 
pathways, where TET1 catalyze the oxidation of 5mC to 5-hydroxymethylcytosine 
(5hmC) and successive oxidation of 5hmC to 5-formylcytosine (5fC) and 5-
carboxycytosine (5caC), and deamination by AID/APOBEC. More efficient DNA 
demethylation is accomplished in plants by the DEMETER 5-methylcytosine DNA 
glycosylase, which mediates direct excision of 5mC from double strand DNA.  
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In order to see if this plant DME is working properly in animal systems, 
Arabidopsis DME gene was introduced into human HEK-293T cells. DME was a 
successfully implemented to remove 5mC and it led to dysregulation of cell 
proliferation, cell cycle arrest at S phase, and severe DNA damage. Gene expression 
profile showed that diverse genes were differentially expressed in DME expressing 
cells such as cell cycle component genes, heat shock proteins, and interferon 
stimulated genes (ISGs). Interestingly, DME expressing cells seem to induce 
antiviral response through the dsRNA generated from activation of retrotransposons. 
Furthermore, DME could be a novel candidate for epigenome editing via the 
successful excision of 5mC in animal cells. DME appears to activate specific 
endogenous gene expression in combination with TALE module and nuclease 
deficient CRISPR/Cas9 and, which induced DNA demethylation at the specific locus. 
 These works demonstrated that plant DNA demethylase catalyzed DNA 
demethylation and the interferon signaling played a crucial role to relieve genotoxic 
stresses in this DME-induced DNA demethylation processes in mammalian cells. 
Furthermore, DME can be utilized for specific gene regulation in DNA methylation 
associated disease and may shed light on the role of DNA methylation in human 
disease. 
Keywords: DEMETER, DNA methylation, DNA demethylation, TET, TALE, 
CRISPR/Cas9 
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Epigenetics refers to a heritable change in DNA and histones that 
affects gene expression without the modification of the DNA sequence. DNA 
methylation, along with histone modification and small RNAs, is one of the 
major epigenetic mechanisms. The genetic information is encoded by DNA, 
which is composed of four canonical bases: thymine, cytosine, guanine, and 
adenine. DNA methylation involves adding the methyl group to the 5-position 
of cytosine, producing 5-methylcytosine (5mC). 5mC, referred to as the fifth 
base, is present in most plants, animals, and fungi. DNA methylation is related 
to gene expression, cell differentiation/development, genomic imprinting, and 
X chromosome inactivation. Cytosine methylation, which is mediated by 
DNA methyltransferase, is generated by a similar mechanism in plants and 
animals. In animals, DNA methylation occurs only in the CpG context, but in 
plants, it occurs at every cytosine at CpG, CpHpG, and CpHpH, where H is 
any nucleotide. The reverse process of DNA methylation is called DNA 
demethylation, which is the process of removing 5mC from DNA and 
replacing it with cytosine. DNA demethylation occurs in two different ways: 
passive and active. Passive DNA demethylation takes place during DNA 
replication by inhibiting the maintenance of DNA methylation, whereas 
active DNA demethylation removes 5mC from DNA using enzymatic 
3 
 
machinery. Active DNA demethylation in animals consists of a very complex 
mechanism involving many enzymes. However, in plants, 5mC is directly 
removed by DNA demethylase, which is a more simple and efficient 
mechanism than that in animals. This review discusses DNA methylation and 
DNA demethylation in both plants and animals.  
 
Epigenetics 
In 2001, the first draft of the human genome sequence was released by 
Venter et al. and Lander et al. At that time, people hoped to understand the complex 
biological system using the revealed genetic code. Although the human genetic code 
has been discovered, not every phenomenon has been explained. For example, 
although they have the same genomes, identical twins show slightly different 
phenotypes (Fraga et al., 2005). Moreover, a single fertilized cell begins to develop 
into several organs with the same DNA sequences in mammals, which implies that 
there are other mechanisms beyond genetic code. . Epigenetics can explain what 
cannot be explained by genetic code alone. The definition of epigenetics is as follows: 
“The study of mitotically and/or meiotically heritable changes in gene function that 
cannot be explained by changes in DNA sequence.” (Russo et al.,1996; Bird, 2002). 
Epigenetic mechanisms consist of three major factors, DNA methylation, histone 
modification, and small RNAs, and these three factors work together to regulate gene 





DNA methylation occurs when a methyl group is added to one of the DNA 
bases by DNA methyl transferase. DNA methylation occurs in both prokaryotes and 
eukaryotes. In prokaryotes, it occurs in two of the four DNA bases, cytosine and 
adenine, (Casadesus and Low, 2006), whereas in eukaryotes, it only occurs in 
cytosine residues (Bird, 2002). DNA methylation is associated with regulating many 
critical biological processes, such as gene imprinting, silencing of transposable 
elements, and X-chromosome inactivation (Bird, 2002; Law and Jacobsen, 2010; 
Wu and Zhang, 2010). 
The inhibition of gene expression by DNA methylation is divided into two 
types: direct and indirect (Bird, 2002). In direct inhibition, transcription factors are 
prevented from binding the DNA when CpG is methylated. For example, 
transcription factor CTCF is not able to bind the promoter region of the paternal 
allele of mouse imprinting gene H19 due to the methylation (Bell and Felsenfeld, 
2000; Hark et al., 2000; Kanduri et al., 2000; Phillips and Corces, 2009; Szabo et al., 
2000). In indirect inhibition, gene expression is disturbed by methyl-CpG-binding 
domain proteins (MBDs), which bind to methylated DNA. Four of the five MBDs 
(i.e., MBD1, MBD2, MBD3, and MeCP2) have been found to result in the 
methylation-dependent repression of transcription (Bird and Wolffe, 1999). One of 
the critical functions of MBDs is the generation of inactive chromatin, called 




In humans, DNA methylation mainly occurs in the symmetric CG context, 
and 5mC constitutes 1% of human DNA. About 70–80% of all CG dinucleotides are 
methylated in mammals. In addition, a small amount of non-CG methylation exists 
in embryonic stem cells (Bird, 2002; Ehrlich et al., 1982; Ramsahoye et al., 2000; 
Lister et al., 2009). In plants, on the other hand, DNA methylation can occur in every 
context of cytosine: CG, CHG, and CHH, where H represents any nucleotide except 
guanine (Chan et al., 2005). For example, in Arabidopsis, DNA methylation occurs 
at the levels of 24% for CG, 6.7% for CHG, and 1.7% for CHH (Cokus et al., 2008). 
 
DNA methyltransferase 
DNA methyltransferase catalyzes a methyl group from S-adenosyl-L-
methionine to carbon 5 of cytosine, generating 5-methylcytosine. DNA 
methyltransferases are divided into four distinct families based on the sequence 
homology within their C-terminal catalytic domains. The families include DNA 
methyltransferase 1, 2, and 3 A/B (DNMT1, DNMT2, and DNMT3 A/B, 
respectively) and DNM3L in mammals and DNA methyltransferase 1 (MET1), 
DNMT2, domains rearranged methyltransferase 1/2 (DRM 1/2), and 
chromomethylase 3 (CMT3) in plants. (Gloll and Bestor, 2005; Law and Jacobsen, 
2010). Although DNMT2 has well-conserved catalytic motifs in the domain of DNA 
cytosine methyltransferase, there is no evidence that it causes cytosine methylation 
(Gloll and Bestor, 2005). 
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DNA methyltransferases are classified by DNA methylation patterns into 
de novo DNA methyltransferases and maintenance methyltransferases. Maintenance 
methyltransferases go from being hemimethylated to fully methylated during DNA 
replication. De novo methylation produces a new methylation pattern. In mammals, 
maintenance methyltransferases are established by DNMT1, and de novo 
methyltransferases are part of the DNMT3 family. In plants, the de novo methylation 
pattern is accepted by DNMT3 homology methyltransferase DRM2 at asymmetric 
CHH. Moreover, the maintenance pattern of CG and CHG methylation is maintained 
by MET1 and CMT3. CMT3 is a plant-specific type of DNA methyltransferase 
(Smallwood and Kelsey, 2012; Bird, 2002; Gloll and Bestor, 2005; Law and 
Jacobsen, 2010; Chan et al., 2005).  
 
DNA methyltransferase in mammals 
In mammals, DNMT1 enables the maintenance of DNA methylation. 
DNMT1 rebuilds hemimethylated DNA to generate fully methylated DNA during 
DNA replication. Ubiquitin-like plant homeodomain and RING finger domain 1 
(UHRF1) is required for the association of DNMT1 with chromatin. The SET- or 
RING- associated (SRA) domain of UHRF1 specifically binds to the 
hemimethylated CG dinucleotide. As a result, UHRF1 recruits DNMT1 to create 
hemimethylated DNA (Arita et al., 2008; Bostick et al., 2007; Sharif et al., 2007). 
Severe mutations of UHRF1 decrease DNA methylation (Bostick et al., 2007; Sharif 
et al., 2007).  
7 
 
DNMT3A and DNMT3B catalyze de novo methylation during early 
embryogenesis (Sasaki and Matsui, 2008), and DNMT3L, which lacks DNA 
methyltransferase activity, functions as a regulatory factor (Grace Goll and Bestor, 
2005). DNMT3A and DNMT3B are able to methylate both hemi- and unmethylated 
substrates at an equal rate (Okano et al., 1998). DNMT3L interacts with DNMT3A 
and DNMT3B, as demonstrated by coimmunoprecipitation (Hata et al., 2002). In 
addition, co-crystallization shows the interaction between DNMT3A and DNMT3L 
(Jia et al., 2007). DNMT3L binds to the unmethylated H3K4 tail (Ooi et al., 2007). 
According to a proposed de novo methylation model, DNMT3L binds to the 
unmodified H3K4 tail and recruits DNMT3A to target loci. The proposed model is 
reliable, because the H3K4 binding-deficient mutant of DNMT3L reduces de novo 
methylation activity in vivo. (Ooi et al., 2010; Hu et al., 2009).  
 
DNA methyltransferase in plants 
In plants, MET1 is the first plant DNA methyltransferase based on the 
sequence similarity of DNMT1 in Arabidopsis thaliana (Jean and Dennis, 1993), 
and it is needed for the maintenance of CG methylation. In addition, like DNMT1, 
MET1 is required for the VARIANT IN METHYLATION (VIM, also known as 
ORTHRUS) family of SRA domain proteins, counterparts of UHRF1 (Woo et al., 
2008; Law and Jacobsen, 2010). Another maintenance DNA methyltransferase, 
CMT3, is responsible for CHG methylation, and CMT3 and the histone 
methyltransferase SUPPRESSOR OF VARIEGATION 3-9 HOMOLOGUE 4 
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(SUVH4, also known as KRYPTONITE) complement each other. SUVH4 
specifically binds to CHG methylation, and then the SRA domain of SUVH4 
catalyzes histone 3 lysine 9 dimethylation (H3K9me2). Moreover, the 
chromodomain of CMT3 recognizes the modification region of H3 tails, and 
neighboring CHG sites are methylated by the methyltransferase domain of CMT3 
(Johnson et al., 2007; Law and Jacobsen, 2010; Lindroth et al., 2004)  
De novo DNA methylation is mediated by RNA-directed DNA methylation 
(RdDM). RdDM requires two plant-specific RNA polymerases, Pol IV and Pol V, as 
well as RNA interference (RNAi) machinery proteins (DCL3 and AGO4) and DRM2 
(Law and Jacobsen, 2010; Matzke et al., 2015). RdDM is initiated by Pol IV, which 
is produced in long single-stranded RNA (ssRNA) transcripts corresponding to 
transposons and repeat elements. The ssRNA is changed to dsRNA by the RNA-
dependent RNA polymerase 2 (RDR2). These transcripts are digested into 24-
nucleotides by DCL3, which are methylated at the 3`-OH group by HUA 
ENHANCER 1 (HEN1) for stabilization (Ji and Chen, 2012) and loaded into AGO4. 
The siRNA-loaded AGO4 interacts with KOW DOMAIN-CONTAINING 
TRANSCRIPTION FACTOR 1 (KTF1, also known as SPT5L) subunits of Pol V. 
During Pol V-mediated transcription, the AGO-bound siRNA is a base pair with the 
nascent Pol V transcript and recruited DRM2. Finally, target loci are established 
through DNA methylation by DRM2 with the assistance of the chromatin-modifying 





DNA demethylation is the reverse process of DNA methylation. This 
process involves the removal of a methyl group from DNA. DNA demethylation is 
necessary for development. For example, in mammals, the paternal genome is 
rapidly demethylated after fertilization in the absence of replication (Mayer et al., 
2000; Oswald et al., 2000; Wu and Zhang, 2010), whereas the maternal genome 
undergoes a gradual loss of methylation with cell division after fertilization before 
blastocyst (Monk et al., 1987; Howlett and Reik, 1991; Wu and Zhang, 2010). As 
mentioned above, DNA demethylation can either occur passively, by DNA 
replication cycles in the absence of maintenance methylation, or actively, 
independent of DNA replication. (Kress et al., 2001; Butani et al., 2011; Wu and 
Zhang, 2014). 
In addition, the base excision repair (BER) pathway is needed for active 
DNA demethylation. The BER pathway is essential to repair damaged DNA or 
mismatched bases. It is initiated by a DNA glycosylase that recognizes and removes 
the damaged base, leaving an abasic site. Moreover, the process is completed by AP-
endonuclease, an exonuclease, a DNA polymerase, and a ligase. In addition, BER is 
divided into short-patch (a single nucleotide gap) and long-patch (2–10 nucleotide 
gaps) repair. The above pathways are decided by a different kind of DNA glycosylase; 
for example, the abundant nonhistone protein high-mobility group box 1 (HMGB1) 
stimulates the long-patch pathway. Short-patch BER requires several proteins, 
including AP-endonuclease APE1, DNA polymerase β (Pol β), and DNA ligase I or 
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III (LIG1/3), but these proteins do not participate in replication. However, long-patch 
BER mainly occurs in proliferation cells, including APE1, DNA polymerase δ/ε, 
PCNA, FEN1, and LIG1 (Krokan and Magnar, 2013). In mammals, active DNA 
demethylation is acquired by the short-patch BER pathway. However, in plants, 
long-patch repair is proposed, because short-patch repair enzymes, such as DNA 
polymerase β and DNA ligase III, have not been identified (Law and Jacobsen, 2010). 
 
Active DNA demethylation in mammals 
Unlike with DNA demethylation in plants, orthologs of the DME family 
have not been identified in mammals. Therefore, mammalian cells have to obtain 
another mechanism for active DNA demethylation. Several types of active DNA 
demethylation mechanisms have been proposed. The most reliable methods are the 
oxidation pathway involving the Ten-eleven Translocation (Tet) family and the 
deamination pathway involving activation-induced deaminase 
(AID)/Apolipoprotein B (Butani et al., 2011; Wu and Zhang, 2014). These active 
DNA demethylation mechanisms involve the BER pathway. 
The first DNA oxidation enzymes discovered were JBP1 (J-binding protein 
1) and JBP2. These enzymes oxidize thymine in the DNA to 5-hydroxylmethyluracil 
(5-hmU). Moreover, base J (β-D-glucosyl-hydroxymethyluracil), the final product 
of oxidization, is achieved by using glycosyltransferase to add a glucose group to 
5hmU. Base J is present in the genome of the parasite Trypanosoma brucei that 
causes African sleeping sickness (Borst and Sabatini, 2008). Base J has a gene 
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silencing function like 5mC; for example, variant surface glycoprotein (VGS) is 
suppressed by base J located at the expression site, whereas base J is absent at these 
sites when VGS is expressed (van Leeuwen et al., 1997).  
JBP 1 and 2 are members of the Fe(II)/α-ketoglutarate (α-KG)–dependent 
dioxygenase family. The homology of JBP1 and 2 proteins has been identified in 
humans, such as Ten-eleven translocation protein 1 (Iyer et al., 2009). TET1 is a 
fusion partner of the H3 Lys4 methyltransferases mixed-lineage leukemia 1 (MLL1) 
in certain types of myeloid leukemia (Lorsbach et al., 2003; Ono et al., 2002). The 
overexpression of TET1 cultured cells leads to a reduction of the 5mC level, and the 
recombinant of TET1 protein can oxidize 5mC to 5hmC in vitro (Tahiliani et al., 
2009). In addition, TET2 and TET3, other proteins of the TET family, can oxidize 
5mC to 5hmC (Ito et al., 2010). TET proteins can further oxidize 5hmC to 5fC and 
5caC (Ito et al., 2011; He et al., 2011). Thymine DNA glycosylase (TDG) is a 
member of the uracil DNA glycosylase (UDG) family. It excises 5fC and 5caC in 
double-stranded oligonucleotides in vitro but cannot effectively remove 5mC and 
5hm (He et al., 2011; Maiti and Drohat, 2011). TDG is already known to remove TG 
or UG mismatched bases to initiate BER (Stivers and Jiang, 2003). In one study, the 
overexpression of TET and TDG in HEK293 cells rapidly diminished levels of 5fC 
and 5caC (Nabel et al., 2012), and TDG mutations in mouse ESCs exhibited 5- to 
10-fold increases in levels of 5fC and 5caC (Shen et al., 2013; Song et al., 2013). In 
addition, TET-TDG-mediated active demethylation was supported by in vitro 
reconstitution (Weber et al., 2016). 
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AID, a member of the AID/apolipoprotein B mRNA-editing catalytic 
polypeptides (APOBEC) family, can deaminate cytosine (C) to uracil (U) and as a 
result generate a U:G mismatch in DNA (Bransteitter et al., 2003). In one study, AID 
and APOBEC1 (found only in mammals) caused a T:G mismatch from the 
deamination of 5mC that could be repaired by TDG and downstream enzymes of the 
BER pathway (Morgan et al., 2004; Ramiro and Barreto, 2015; Bhutani et al., 2010). 
The male and female primordial germ cells (PGCs) derived from AID-null embryos 
increased levels of DNA methylation in a mouse model (Popp et al., 2010). In 
addition, the authors proposed that AID can deaminate 5hmC to 5hmU (Guo et al., 
2011). 
 
Active demethylation in plants 
In plants, active DNA demethylation is achieved by 5mC DNA 
glycosylases combined with the BER pathway. Arabidopsis DEMETER family 
(DME, ROS1, DML2, and DML3) proteins are DNA glycosylases that directly 
remove 5mC, creating an abasic site (Gehring et al., 2006; Penterman et al., 2007). 
BER pathway enzymes repair the abasic site and perform the subsequent 
replacement with cytosine (Gehring et al., 2009a).  
DME is a 5mC excision demethylase (Gehring et al., 2006; Mok et al., 
2010), and it excises 5hmC (Jang et al., 2014). DME was identified in a mutant 
screening from the seed abortion phenotype of Arabidopsis. DME is primarily 
expressed in the central cell of the maternal gametophyte, and it is required for 
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endosperm development. In addition, homozygote DME mutants exhibit 
developmental abnormalities, such as increased or decreased petal or sepal numbers 
(Choi et al., 2002). DME is the bifunctional imprinting gene of DNA 
glycosylase/AP-lyase (Gehring et al., 2006). . It is required for the expression of 
maternal allele-specific imprinting genes MEDEA (MEA), FLOWERING 
WAGENINGEN (FWA), FERTILIZATION INDEPENDENT SEED 2 (FIS2) before 
fertilization (Choi et al., 2002; Kinoshita et al., 2004; Gehring et al., 2006, 2009a; 
Huh et al., 2008), and it contributes to genome-wide demethylation in the endosperm 
(Gehring et al., 2009b). In addition, DME is expressed in pollen, and it is required 
for the demethylation of MEA, FWA, and Mu1a transposon (Schoft et al., 2011). 
DME is composed of three conserved domains, domains A and B and a glycosylase 
domain, and it is composed of 1,729 amino acids (Mok et al., 2010). Domain A has 
DNA binding activity, which has been confirmed by gel mobility shift assays. In 
addition, Domain B is essential for 5mC excision, but its exact function is unknown. 
The glycosylase domain of DME plays an essential role in 5mC excision. It contains 
four conserved cysteine residues that comprise a [4Fe-4S] cluster, which is found in 
other glycosylases as well, such as MutY and Endonuclease III (EndoIII) in E. coli 
and human 8-oxoguanine DNA glycosylase (hOGG1) (Mok et al., 2010; Guan et al., 
1998; Kuo et al., 1992; Bruner et al., 2000). DME contains aspartic acid (Asp1304) 
and Lysine (Lys1286) residues, which are necessary for glycosylase function in vitro 
(Mok et al., 2010). When the aspartic acid residue is mutated to asparagine 




Other genes are expressed in vegetative tissue and protect from 
inappropriate DNA methylation (Gong et al., 2002; Ortega-Galisteo et al., 2008). 
Ros1 mutant plants show developmental abnormalities, such as fewer seeds, retarded 
growth, and low silique vascular expression. Furthermore, the mutation of Ros1 
causes transgene silencing and sensitivity to hydrogen (Gong et al., 2002). DML2 
and DML3 appear to catalyze demethylation, but their function is unknown 
(Penterman et al., 2007). 
 
Genome editing 
In the last decade, genome-editing technology has developed at a 
tremendous speed, and it is still developing. Genome-editing systems have to fuse 
the two different kinds of functional domains, such as a sequence-specific DNA 
binding domain and a nonspecific nuclease. The chimeric protein recognizes the 
specific DNA locus and generates the DNA double-strand breaks (DSBs) that the 
cleavage sites repair using the cellular DNA repair system. In eukaryotes, DNA 
repair systems come in two main types: non-homologous end-joining (NHEJ) 
(Lieber, 2010) and homologous recombination (HR) (Sung and Klein, 2006). NHEJ 
is directly ligated without the homolog template, and it is often present in the single-
stranded overhangs of DSBs. If the overhangs are entirely correct, the DSBs are 
accurately repaired, whereas the incorrect overhangs cause imprecise DNA 
sequences, such as nucleotide insertions, deletions, or substitutions. HR involves 
genetic recombination, and it usually repairs DNA sequences precisely. HR is used 
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for exogenous DNA sequence insertion at the DSB site in the genome during genome 
editing. 
Genome-editing systems are divided into two types based on whether they 
involve a protein–DNA complex or a nucleotide–nucleotide covalent bond. The zinc 
finger (ZF) domain and transcription activator-like effectors (TALEs) are examples 
of protein–DNA complexes, and the clustered regularly interspaced short 
palindromic repeat (CRISPR)/Cas (CRISPR-associated protein) is an example of a 
nucleotide–nucleotide covalent bond. 
 
Zinc finger domain  
The ZF domain was first discovered in TFIIA of Xenopus laevis (Miller et 
al., 1985) and it is the most common type of DNA-binding motif in eukaryotes and 
the most abundant human transcription factor in the human genome (Tupler et al., 
2001). Each Cys2-His2 ZF domain consists of 30 amino acids, and its structure 
configuration is ββα in the presence a zinc atom (Lee et al., 1989). The two Cys 
residues constitute two β-sheets, and two His residues constitute the α-helix 
(Gommans et al., 2005). The α-helix of each ZF domain binds to three contiguous 
base pairs in the major groove of the DNA. (Wolfe et al., 2000). For genome editing, 
3–6 ZF domains need to bind to a specific DNA sequence of 9–18, where each of 
the ZF domains is connected with a conserved linker (Liu et al., 1997). In order to 
edit a specific sequence, the editing module has to be assembled according to the 
target base sequence among the binding triplet sequence discovered from the 64 ZF 
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domains (Segal et al., 1999).  
 
Transcription activator-like effectors (TALEs) 
TALEs are derived from the plant pathogen species Xanthomonas spp. 
TALEs infect plants by type III secretion of a bacterial invasion system and act as a 
transcription activator to bind specific target gene promoters (Boch and Bonas, 2010). 
TALEs consist of a type III translocation signal of the N-terminal, specific DNA 
binding of the central domain, and the transcriptional activation domain of the C-
terminal. The central DNA-binding domain is composed of tandem monomer repeats, 
and the number varies between 1.5 and 33.5 (average is 17.5). Each repeat binds to 
a single base pair in the major groove of the DNA. Each repeat contains 33–35 amino 
acids, and the 12- and 13-position residues, called repeat variable diresidues (RVDs), 
determine the nucleotide binding specificity (Boch and Bonas, 2010; Miller et al., 
2011; Scholze and Boch, 2010). In the crystal structure of TALEs, the 13-position 
residue specifically binds DNA, and the 12-position residue stabilizes the 
conformation (Mak et al., 2012; Deng et al., 2012). The DNA binding specificity is 
determined by the RVDs, with A, C, G, T, AG, and N (N= A, C, G, T) recognized by 
NI (Asn Ile), HD (His Asp), NH (Asn His), NG (Asn Gly), NN (Asn Asn), and NS 
(Asn Ser), respectively. Moreover, the binding sequence of TALE has to start with 
thymine (Boch et al., 2009; Moscou and Bogdanove, 2009; Scholze and Boch, 2010; 
Cong et al., 2012; Streubel et al., 2012).  
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For genome editing, TALEs require deletion of unnecessary functional 
regions such as the N-terminal translocation signal and the C-terminal transcriptional 
activation domain. However, minimal regions of N- and C-terminals for 
conformation stability to maintain the DNA binding function must remain. The N-
terminal deletion forms of TALEs, such as 152 or 153 amino acids removal, did not 
show diminution of TALEs activity and, at least over 140 amino acids were 
necessary for DNA binding activity (Miller et al., 2011; Mussolino et al., 2011, Gao 
et al., 2012). The 17 amino acids remaining in the C-terminal domain still maintain 
the DNA binding activity of TALEs (Mussolino et al., 2011). However, the C-
terminal domain needs additional length when a different functional domain is fused 
to the TALEs, such as transcription activation domain, nuclease domain, or histone 
modification factors (Miller et al., 2011).     
 
CRISPR/Cas9  
 30 years ago, the CRISPRs were found in the E. coli genome, and these 
sequences were well conserved in 40% of all sequenced bacterial genomes (Sorek et 
al., 2008). The CRISPR/Cas system has been the most widely used genome-editing 
tool since 2013, but it is an adaptive immune system of bacteria and archaea that 
serves as a CRISPR RNA (crRNA)-guided defense system for cleavage of the 
invasion viral genome or plasmids (Wang et al., 2016). The CRISPR/Cas systems 
are divided into two major classes. The class 1 systems (types I, III, and IV) require 
a large complex of several components, but the class 2 systems (types II, V and VI) 
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need only one RNA-guided endonuclease like Cas9 or Cpf1Makarova et al., 2015; 
Wang et al., 2016). The type II (Cas9) is the most widely used for genome editing, 
and type V (Cpf1) has only recently been used (Zetsche et al., 2015; Kim et al., 
2016).    
 Cas9 is guided to specific cleavage sites by duplex of two RNAs such as 
crRNA and tracrRNA (trans-acting CRISPR RNA). The functions of the two RNAs 
are as follows: the crRNA recognizes the target sequence through an approximately 
20-base pair by the Watson–Crick complementation rule, and the tracrRNA 
hybridizes with the crRNA. To optimize these two RNAs for simplifying the system, 
the crRNA-tracrRNA was fused to a chimeric single guide RNA (sgRNA) (Jinek et 
al., 2012). Cas9 requires the HNH and RuvC domains to generate DNA breaks. The 
NHN domain cleaves the specific sequence that is complementary to the 20-
nucleotide sequence of crRNA, and the RuvC domain cleaves the opposite the 
complementary strand. These two nuclease domains of Cas9 cleave the 3-nucleotide 
upstream region of the protospacer adjacent motif (PAM) sequence. The PAM  is 
located at the immediately 3` end region of the target sequence and consists of NGG 
or a weaker NAG sequence (where N is any nucleotide) (Doudna and Charpentier, 
2014; Wang et al., 2016)  
The CRISPR/Cas9 system widely are using for genome editing because ZF 
domain and TALEs contain some disadvantage. The ZF domains are limited by low 
targeting efficiency. In addition, TALEs need for specific cloning technic such as 
‘Golden Gate’ system since it is difficult to assemble TALEs repeats by standard 
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cloning technic. On the other hand, CRISPR/Cas9 is much easier, cheaper, and high 
target efficiency than others. For example, CRISPR/Cas9 is easy to design target 
sequence just decide to about 20nt oligonucleotides upstream of PAM. Another 
advantage is that it is possible to target multiple loci simultaneously in a host (Cong 
et al., 2013). The off-target sites of Cas9 are detected under 10 to1000 sites 
depending on the sgRNA in the human genome (Kuscu et al., 2014), which is not 
high. This off-target ratio is not sufficient for human therapy. For increasing the 
sgRNA specificity, 5` truncated sgRNA improves target specificity and Cpf1, 
another type of Cas9, does not produce off-target cleavage (Kim et al., 2016).     
 
Beyond genome editing 
 The above three types of genome editing systems are using for specific gene 
regulation, possibly adding different types of functional domains such as 
transcription activation factors, histone modification enzymes, DNA 
methyltransferase, or DNA demethylase (Wang et al., 2016; Urnov et al., 2010; Gaj 
et al., 2013.) For sequence specific gene regulation, Cas9 has to mutate two cleavage 
domain residues, such as D10 to 10A and H840 to 840A, which is called deadCas9 
(dCas9) (Wang et al., 2016). The VP64 is composed four tandem copies of VP16 
(Herpes Simplex Viral Protein 16), which is a transcriptional activator. The amino 
acid sequences `DALDDFDLDML` are connected with glycine-serine (Seipel et al., 
1992; Beerli et al., 1998). The VP64 has been linked with TALEs and 
CRISPR/dCas9; each fusion protein activates the downstream associated specific 
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gene. OCT4 (POU5F1) and VEGFA are activated by TALE-VP64 and dCas9-VP64, 
respectively (Hu et al., 2014; Maeder et al., 2013a; Maeder et al., 2013b). In addition, 
dCas9-KRAB fusion proteins suppress the targeted downstream reporter gene, and 
the Krüppel-associated box (KRAB) is a domain of the KOX1 (also known as a 
ZNF10), which is a transcriptional repressor (Thakore et al., 2015). The conjugation 
of human histone acetyltransferase p300 with dCas9 activates OCT4, MYOD, and 
IL1RN. Interestingly, the activation core region of p300 (dCas9-p300 core) activates 
downstream target genes more than dCas9-VP64. The fusion proteins TALE-TET 
and dCas9-TET induce expression of the downstream gene and DNA demethylation 
at the target region (Maeder et al., 2013c, Xu et al., 2016, Morita et al., 2016). The 
function of TET protein induces DNA demethylation through oxidation of 5mC to 









Arita, K., Ariyoshi, M., Tochio, H., Nakamura, Y., Shirakawa, M. (2008). 
Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a 
base-flipping mechanism. Nature 455, 818-821. 
Beerli, R. R., Segal, D. J., Dreier, B., Barbas, C. F., 3rd (1998). Toward controlling 
gene expression at will: specific regulation of the erbB-2/HER-2 promoter 
by using polydactyl zinc finger proteins constructed from modular 
building blocks. Proc. Natl. Acad. Sci. USA 95, 14628-14633. 
Bell, A. C., Felsenfeld, G. (2000). Methylation of a CTCF-dependent boundary 
controls imprinted expression of the Igf2 gene. Nature 405, 482-485. 
Bhutani, N., Brady, J. J., Damian, M., Sacco, A., Corbel, S. Y., Blau, H. M. (2010). 
Reprogramming towards pluripotency requires AID-dependent DNA 
demethylation. Nature 463, 1042-1047. 
Bhutani, N., Burns, D. M., Blau, H. M. (2011). DNA demethylation dynamics. Cell 
146, 866-872. 
Bird, A. (2002). DNA methylation patterns and epigenetic memory. Genes Dev. 16, 
6-21. 
Bird, A. (2007). Perceptions of epigenetics. Nature 447, 396-398. 
Bird, A., Wolffe, A. (1999). Methylation-induced repression—belts, braces, and 
chromatin. Cell 99, 451-454. 
Boch, J., Bonas, U. (2010). Xanthomonas AvrBs3 family-type III effectors: 
discovery and function. Annu. Rev. Phytopathol. 48, 419-436. 
22 
 
Boch, J., Scholze, H., Schornack, S., Landgraf, A., Hahn, S., Kay, S., Lahaye, T., 
Nickstadt, A., Bonas, U. (2009). Breaking the code of DNA binding 
specificity of TAL-type III effectors. Science 326, 1509-1512. 
Borst, P., Sabatini, R. (2008). Base J: discovery, biosynthesis, and possible functions. 
Annu. Rev. Microbiol. 62, 235-251. 
Bostick, M., Kim, J. K., Esteve, P. O., Clark, A., Pradhan, S., Jacobsen, S. E. (2007a). 
UHRF1 plays a role in maintaining DNA methylation in mammalian cells. 
Science 317, 1760-1764. 
Bransteitter, R., Pham, P., Scharff, M. D., Goodman, M. F. (2003). Activation-
induced cytidine deaminase deaminates deoxycytidine on single-stranded 
DNA but requires the action of RNase. Proc. Natl. Acad. Sci. USA 100, 
4102-4107. 
Bruner, S. D., Norman, D. P., Verdine, G. L. (2000). Structural basis for recognition 
and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature 403, 
859-866. 
Casadesus, J., Low, D. (2006). Epigenetic gene regulation in the bacterial world. 
Microbiol. Mol. Biol. Rev. 70, 830-856. 
Chan, S. W., Henderson, I. R., Jacobsen, S. E. (2005). Gardening the genome: DNA 
methylation in Arabidopsis thaliana. Nat. Rev. Genet. 6, 351-360. 
Choi, Y., Gehring, M., Johnson, L., Hannon, M., Harada, J. J., Goldberg, R. B., 
Jacobsen, S. E., Fischer, R. L. (2002). DEMETER, a DNA glycosylase 
domain protein, is required for endosperm gene imprinting and seed 
viability in Arabidopsis. Cell 110, 33-42. 
23 
 
Choi, Y., Harada, J. J., Goldberg, R. B., Fischer, R. L. (2004). An invariant aspartic 
acid in the DNA glycosylase domain of DEMETER is necessary for 
transcriptional activation of the imprinted MEDEA gene. Proc. Natl. Acad. 
Sci. USA 101, 7481-7486. 
Cokus, S. J., Feng, S., Zhang, X., Chen, Z., Merriman, B., Haudenschild, C. D., 
Pradhan, S., Nelson, S. F., Pellegrini, M., Jacobsen, S. E. (2008). Shotgun 
bisulfite sequencing of the Arabidopsis genome reveals DNA methylation 
patterning. Nature 452, 215-219. 
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., 
Jiang, W., Marraffini, L. A., et al. (2013). Multiplex genome engineering 
using CRISPR/Cas systems. Science 339, 819-823. 
Cong, L., Zhou, R., Kuo, Y. C., Cunniff, M., Zhang, F. (2012). Comprehensive 
interrogation of natural TALE DNA-binding modules and transcriptional 
repressor domains. Nat. Commun. 3, 968. 
Deng, D., Yan, C., Pan, X., Mahfouz, M., Wang, J., Zhu, J. K., Shi, Y., Yan, N. (2012). 
Structural basis for sequence-specific recognition of DNA by TAL 
effectors. Science 335, 720-723. 
Doudna, J. A., Charpentier, E. (2014). Genome editing. The new frontier of genome 
engineering with CRISPR-Cas9. Science 346, 1258096. 
Du, Q., Luu, P., Stirzaker, C., Clark, S. J. (2015). Methyl-CpG-binding domain 
proteins: readers of the epigenome. Epigenomics 7, 1051-1073. 
Ehrlich, M., Gama-Sosa, M. A., Huang, L. H., Midgett, R. M., Kuo, K. C., McCune, 
R. A., Gehrke, C. (1982). Amount and distribution of 5-methylcytosine in 
24 
 
human DNA from different types of tissues of cells. Nucleic Acids Res. 10, 
2709-2721. 
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-
Suner, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005). 
Epigenetic differences arise during the lifetime of monozygotic twins. 
Proc. Natl. Acad. Sci. USA 102, 10604-10609. 
Gaj, T., Gersbach, C. A., Barbas, C. F., 3rd (2013). ZFN, TALEN, and CRISPR/Cas-
based methods for genome engineering. Trends Biotechnol. 31, 397-405. 
Gao, H., Wu, X., Chai, J., Han, Z. (2012). Crystal structure of a TALE protein reveals 
an extended N-terminal DNA binding region. Cell Res. 22, 1716-1720. 
Gehring, M., Bubb, K. L., Henikoff, S. (2009b). Extensive demethylation of 
repetitive elements during seed development underlies gene imprinting. 
Science 324, 1447-1451. 
Gehring, M., Huh, J. H., Hsieh, T. F., Penterman, J., Choi, Y., Harada, J. J., Goldberg, 
R. B., Fischer, R. L. (2006). DEMETER DNA glycosylase establishes 
MEDEA polycomb gene self-imprinting by allele-specific demethylation. 
Cell 124, 495-506. 
Gehring, M., Reik, W., Henikoff, S. (2009a). DNA demethylation by DNA repair. 
Trends Genet. 25, 82-90. 
Goll, M. G., Bestor, T. H. (2005). Eukaryotic cytosine methyltransferases. Annu. Rev. 
Biochem. 74, 481-514. 
Gommans, W. M., Haisma, H. J., Rots, M. G. (2005). Engineering zinc finger protein 
transcription factors: the therapeutic relevance of switching endogenous 
25 
 
gene expression on or off at command. J. Mol. Biol. 354, 507-519. 
Gong, Z., Morales-Ruiz, T., Ariza, R. R., Roldan-Arjona, T., David, L., Zhu, J. K. 
(2002). ROS1, a repressor of transcriptional gene silencing in Arabidopsis, 
encodes a DNA glycosylase/lyase. Cell 111, 803-814. 
Guan, Y., Manuel, R. C., Arvai, A. S., Parikh, S. S., Mol, C. D., Miller, J. H., Lloyd, 
S., Tainer, J. A. (1998). MutY catalytic core, mutant and bound adenine 
structures define specificity for DNA repair enzyme superfamily. Nat. 
Struct. Biol. 5, 1058-1064. 
Guo, J. U., Su, Y., Zhong, C., Ming, G. L., Song, H. (2011). Hydroxylation of 5-
methylcytosine by TET1 promotes active DNA demethylation in the adult 
brain. Cell 145, 423-434. 
Hark, A. T., Schoenherr, C. J., Katz, D. J., Ingram, R. S., Levorse, J. M., Tilghman, 
S. M. (2000). CTCF mediates methylation-sensitive enhancer-blocking 
activity at the H19/Igf2 locus. Nature 405, 486-489. 
Hata, K., Okano, M., Lei, H., Li, E. (2002). Dnmt3L cooperates with the Dnmt3 
family of de novo DNA methyltransferases to establish maternal imprints 
in mice. Development 129, 1983-1993. 
He, Y. F., Li, B. Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, 
L., et al. (2011). Tet-mediated formation of 5-carboxylcytosine and its 
excision by TDG in mammalian DNA. Science 333, 1303-1307. 
Heard, E., Martienssen, R. (2014). Transgenerational epigenetic inheritance: myths 
and mechanisms. Cell 157, 95-109. 
Howlett, S. K., Reik, W. (1991). Methylation levels of maternal and paternal 
26 
 
genomes during preimplantation development. Development 113, 119-127. 
Hu, J. L., Zhou, B. O., Zhang, R. R., Zhang, K. L., Zhou, J. Q., Xu, G. L. (2009). 
The N-terminus of histone H3 is required for de novo DNA methylation in 
chromatin. Proc. Natl. Acad. Sci. USA 106, 22187-22192. 
Hu, J., Lei, Y., Wong, W. K., Liu, S., Lee, K. C., He, X., You, W., Zhou, R., Guo, J. 
T., Chen, X., et al. (2014). Direct activation of human and mouse Oct4 
genes using engineered TALE and Cas9 transcription factors. Nucleic 
Acids Res. 42, 4375-4390. 
Huh, J. H., Bauer, M. J., Hsieh, T. F., Fischer, R. L. (2008). Cellular programming of 
plant gene imprinting. Cell 132, 735-744. 
Ishino, Y., Shinagawa, H., Makino, K., Amemura, M., Nakata, A. (1987). Nucleotide 
sequence of the iap gene, responsible for alkaline phosphatase isozyme 
conversion in Escherichia coli, and identification of the gene product. J. 
Bacteriol. 169, 5429-5433. 
Ito, S., D'Alessio, A. C., Taranova, O. V., Hong, K., Sowers, L. C., Zhang, Y. (2010). 
Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and 
inner cell mass specification. Nature 466, 1129-1133. 
Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., Zhang, 
Y. (2011). Tet proteins can convert 5-methylcytosine to 5-formylcytosine 
and 5-carboxylcytosine. Science 333, 1300-1303. 
Iyer, L. M., Tahiliani, M., Rao, A., Aravind, L. (2009). Prediction of novel families 
of enzymes involved in oxidative and other complex modifications of 
bases in nucleic acids. Cell Cycle 8, 1698-1710. 
27 
 
Jang, H., Shin, H., Eichman, B. F., Huh, J. H. (2014). Excision of 5-
hydroxymethylcytosine by DEMETER family DNA glycosylases. 
Biochem. Biophys. Res. Commun. 446, 1067-1072. 
Jean F., E, Dennis, Elizabeth S (1993). Isolation and identification by sequence 
homology of a putative cytosine methyltransferase from Arabidopsis 
thaliana. Nucleic Acids Res. 21, 2383-2388. 
Ji, L., Chen, X. (2012). Regulation of small RNA stability: methylation and beyond. 
Cell Res. 22, 624-636. 
Jia, D., Jurkowska, R. Z., Zhang, X., Jeltsch, A., Cheng, X. (2007). Structure of 
Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. 
Nature 449, 248-251. 
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., Charpentier, E. (2012). 
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive 
Bacterial Immunity. Science 337, 816-821. 
Johnson, L. M., Bostick, M., Zhang, X., Kraft, E., Henderson, I., Callis, J., Jacobsen, 
S. E. (2007). The SRA methyl-cytosine-binding domain links DNA and 
histone methylation. Curr. Biol. 17, 379-384. 
Kanduri, C., Pant, V., Loukinov, D., Pugacheva, E., Qi, C. F., Wolffe, A., Ohlsson, 
R., Lobanenkov, V. V. (2000). Functional association of CTCF with the 
insulator upstream of the H19 gene is parent of origin-specific and 
methylation-sensitive. Curr. Biol. 10, 853-856. 
Kim, D., Kim, J., Hur, J. K., Been, K. W., Yoon, S., Kim, J. S. (2016). Genome-wide 
analysis reveals specificities of Cpf1 endonucleases in human cells. Nat. 
28 
 
Biotechnol. 34, 863-868 
Kinoshita, T., Miura, A., Choi, Y., Kinoshita, Y., Cao, X., Jacobsen, S. E., Fischer, R. 
L., Kakutani, T. (2004). One-way control of FWA imprinting in 
Arabidopsis endosperm by DNA methylation. Science 303, 521-523. 
Kress, C., Thomassin, H., Grange, T. (2001). Local DNA demethylation in 
vertebrates: how could it be performed and targeted? FEBS Lett. 494, 135-
140. 
Krokan, H. E., Bjoras, M. (2013). Base excision repair. Cold Spring Harb. Perspect. 
Biol. 5, a012583. 
Kuo, C. F., McRee, D. E., Fisher, C. L., O'Handley, S. F., Cunningham, R. P., Tainer, 
J. A. (1992). Atomic structure of the DNA repair [4Fe-4S] enzyme 
endonuclease III. Science 258, 434-440. 
Kuscu, C., Arslan, S., Singh, R., Thorpe, J., Adli, M. (2014). Genome-wide analysis 
reveals characteristics of off-target sites bound by the Cas9 endonuclease. 
Nat. Biotechnol. 32, 677-683. 
Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., 
Devon, K., Dewar, K., Doyle, M., FitzHugh, W., et al. (2001). Initial 
sequencing and analysis of the human genome. Nature 409, 860-921. 
Law, J. A., Jacobsen, S. E. (2010). Establishing, maintaining and modifying DNA 
methylation patterns in plants and animals. Nat. Rev. Genet. 11, 204-220. 
Lee, M. S., Gippert, G. P., Soman, K. V., Case, D. A., Wright, P. E. (1989). Three-
dimensional solution structure of a single zinc finger DNA-binding 
domain. Science 245, 635-637. 
29 
 
Lieber, M. R. (2010). The mechanism of double-strand DNA break repair by the 
nonhomologous DNA end-joining pathway. Annu. Rev. Biochem. 79, 181-
211. 
Lindroth, A. M, Shultis, D., Jasencakova, Z., Fuchs, J., Johnson, L., Schubert, D., 
Patnaik, D., Pradhan, S., Goodrich, J., Schubert, I. (2004). Dual histone 
H3 methylation marks at lysines 9 and 27 required for interaction with 
CHROMOMETHYLASE3. EMBO J 23, 4286-4296. 
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., 
Nery, J. R., Lee, L., Ye, Z., Ngo, Q. M., et al. (2009). Human DNA 
methylomes at base resolution show widespread epigenomic differences. 
Nature 462, 315-322. 
Liu, Q., Segal, D. J., Ghiara, J. B., Barbas, C. F. (1997). Design of polydactyl zinc-
finger proteins for unique addressing within complex genomes. Proc. Natl. 
Acad. Sci. USA 94, 5525-5530. 
Lorsbach, R. B., Moore, J., Mathew, S., Raimondi, S. C., Mukatira, S. T., Downing, 
J. R. (2003). TET1, a member of a novel protein family, is fused to MLL 
in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia 17, 
637-641. 
Maeder, M. L., Angstman, J. F., Richardson, M. E., Linder, S. J., Cascio, V. M., Tsai, 
S. Q., Ho, Q. H., Sander, J. D., Reyon, D., Bernstein, B. E., et al. (2013c). 
Targeted DNA demethylation and activation of endogenous genes using 




Maeder, M. L., Linder, S. J., Cascio, V. M., Fu, Y., Ho, Q. H., Joung, J. K. (2013a). 
CRISPR RNA-guided activation of endogenous human genes. TET1, a 
member of a novel protein family, is fused to MLL in acute myeloid 
leukemia containing the 10, 977-979. 
Maeder, M. L., Linder, S. J., Reyon, D., Angstman, J. F., Fu, Y., Sander, J. D., Joung, 
J. K. (2013b). Robust, synergistic regulation of human gene expression 
using TALE activators. Nat. Methods 10, 243-245. 
Maiti, A., Drohat, A. C. (2011). Thymine DNA glycosylase can rapidly excise 5-
formylcytosine and 5-carboxylcytosine: potential implications for active 
demethylation of CpG sites. J. Biol. Chem. 286, 35334-35338. 
Mak, A. N., Bradley, P., Cernadas, R. A., Bogdanove, A. J., Stoddard, B. L. (2012). 
The crystal structure of TAL effector PthXo1 bound to its DNA target. 
Science 335, 716-719. 
Makarova, K. S., Wolf, Y. I., Alkhnbashi, O. S., Costa, F., Shah, S. A., Saunders, S. 
J., Barrangou, R., Brouns, S. J., Charpentier, E., Haft, D. H., et al. (2015). 
An updated evolutionary classification of CRISPR-Cas systems. Nat. Rev. 
Microbiol. 13, 722-736. 
Matzke, M. A., Kanno, T., Matzke, A. J. (2015). RNA-Directed DNA Methylation: 
The Evolution of a Complex Epigenetic Pathway in Flowering Plants. 
Annu. Rev. Plant Biol. 66, 243-267. 
Mayer, W., Niveleau, A., Walter, J., Fundele, R., Haaf, T. (2000). Demethylation of 
the zygotic paternal genome. Nature 403, 501-502. 
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, 
31 
 
D. E., Leung, E., Hinkley, S. J., et al. (2011). A TALE nuclease architecture 
for efficient genome editing. Nat. Biotechnol. 29, 143-148. 
Miller, J., McLachlan, A. D., Klug, A. (1985). Repetitive zinc-binding domains in 
the protein transcription factor IIIA from Xenopus oocytes. EMBO J. 4, 
1609-1614. 
Mok, Y. G., Uzawa, R., Lee, J., Weiner, G. M., Eichman, B. F., Fischer, R. L., Huh, 
J. H. (2010). Domain structure of the DEMETER 5-methylcytosine DNA 
glycosylase. Proc. Natl. Acad. Sci. USA 107, 19225-19230. 
Monk, M., Boubelik, M., and Lehnert, S. (1987). Temporal and regional changes in 
DNA methylation in the embryonic, extraembryonic and germ cell 
lineages during mouse embryo development. Development 99, 371-382. 
Morgan, H. D., Dean, W., Coker, H. A., Reik, W., Petersen-Mahrt, S. K. (2004). 
Activation-induced cytidine deaminase deaminates 5-methylcytosine in 
DNA and is expressed in pluripotent tissues: implications for epigenetic 
reprogramming. J. Biol. Chem. 279, 52353-52360. 
Morita, S., Noguchi, H., Horii, T., Nakabayashi, K., Kimura, M., Okamura, K., Sakai, 
A., Nakashima, H., Hata, K., Nakashima, K., et al. (2016). Targeted DNA 
demethylation in vivo using dCas9-peptide repeat and scFv-TET1 
catalytic domain fusions. Nat. Biotechnol. 34, 1060-1065. 
Moscou, M. J., Bogdanove, A. J. (2009). A simple cipher governs DNA recognition 
by TAL effectors. Science 326, 1501. 
Mussolino, C., Morbitzer, R., Lutge, F., Dannemann, N., Lahaye, T., Cathomen, T. 
(2011). A novel TALE nuclease scaffold enables high genome editing 
32 
 
activity in combination with low toxicity. Nucleic Acids Res. 39, 9283-
9293. 
Nabel, C. S., Jia, H., Ye, Y., Shen, L., Goldschmidt, H. L., Stivers, J. T., Zhang, Y., 
Kohli, R. M. (2012). AID/APOBEC deaminases disfavor modified 
cytosines implicated in DNA demethylation. Nat. Chem. Biol. 8, 751-758. 
Okano, M., Xie, S., Li, E. (1998). Cloning and characterization of a family of novel 
mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19, 219-
220. 
Ono, R., Taki, T., Taketani, T., Taniwaki, M., Kobayashi, H., Hayashi, Y. (2002). 
LCX, leukemia-associated protein with a CXXC domain, is fused to MLL 
in acute myeloid leukemia with trilineage dysplasia having 
t(10;11)(q22;q23). Cancer Res. 62, 4075-4080. 
Ooi, S. K., Qiu, C., Bernstein, E., Li, K., Jia, D., Yang, Z., Erdjument-Bromage, H., 
Tempst, P., Lin, S. P., Allis, C. D., et al. (2007). DNMT3L connects 
unmethylated lysine 4 of histone H3 to de novo methylation of DNA. 
Nature 448, 714-717. 
Ooi, S. K., Wolf, D., Hartung, O., Agarwal, S., Daley, G. Q., Goff, S. P., Bestor, T. 
H. (2010). Dynamic instability of genomic methylation patterns in 
pluripotent stem cells. Epigenetics Chromatin 3, 17. 
Ortega-Galisteo, A. P., Morales-Ruiz, T., Ariza, R. R., Roldan-Arjona, T. (2008). 
Arabidopsis DEMETER-LIKE proteins DML2 and DML3 are required for 




Oswald, J., Engemann, S., Lane, N., Mayer, W., Olek, A., Fundele, R., Dean, W., 
Reik, W., Walter, J. (2000). Active demethylation of the paternal genome 
in the mouse zygote. Curr. Biol. 10, 475-478. 
Penterman, J., Zilberman, D., Huh, J. H., Ballinger, T., Henikoff, S., and Fischer, R. 
L. (2007). DNA demethylation in the Arabidopsis genome. Proc. Natl. 
Acad. Sci. USA 104, 6752-6757. 
Phillips, J. E., Corces, V. G. (2009). CTCF: master weaver of the genome. Cell 137, 
1194-1211. 
Popp, C., Dean, W., Feng, S., Cokus, S. J., Andrews, S., Pellegrini, M., Jacobsen, S. 
E., Reik, W. (2010). Genome-wide erasure of DNA methylation in mouse 
primordial germ cells is affected by AID deficiency. Nature 463, 1101-
1105. 
Ramiro, A. R., Barreto, V. M. (2015). Activation-induced cytidine deaminase and 
active cytidine demethylation. Trends Biochem. Sci. 40, 172-181. 
Ramsahoye, B. H., Biniszkiewicz, D., Lyko, F., Clark, V., Bird, A. P., Jaenisch, R. 
(2000). Non-CpG methylation is prevalent in embryonic stem cells and 
may be mediated by DNA methyltransferase 3a. Proc. Natl. Acad. Sci. 
USA 97, 5237-5242. 
Russo, V.E.A., Martienssen, R., Riggs, A. D. (1996). Epigenetic mechanisms of gene 
regulation (Cold Spring Harbor Laboratory Press). 
Sasaki, H., Matsui, Y. (2008). Epigenetic events in mammalian germ-cell 
development: reprogramming and beyond. Nat. Rev. Genet. 9, 129-140. 
Schoft, V. K., Chumak, N., Choi, Y., Hannon, M., Garcia-Aguilar, M., Machlicova, 
34 
 
A., Slusarz, L., Mosiolek, M., Park, J. S., Park, G. T., et al. (2011). 
Function of the DEMETER DNA glycosylase in the Arabidopsis thaliana 
male gametophyte. Proc. Natl. Acad. Sci. USA 108, 8042-8047. 
Scholze, H., Boch, J. (2010). TAL effector-DNA specificity. Virulence 1, 428-432. 
Segal, D. J., Dreier, B., Beerli, R. R., Barbas, C. F., 3rd (1999). Toward controlling 
gene expression at will: selection and design of zinc finger domains 
recognizing each of the 5'-GNN-3' DNA target sequences. Proc. Natl. 
Acad. Sci. USA 96, 2758-2763. 
Seipel, K., Georgiev, O., Schaffner, W. (1992). Different activation domains 
stimulate transcription from remote ('enhancer') and proximal ('promoter') 
positions. EMBO J. 11, 4961-4968. 
Sharif, J., Muto, M., Takebayashi, S., Suetake, I., Iwamatsu, A., Endo, T. A., Shinga, 
J., Mizutani-Koseki, Y., Toyoda, T., Okamura, K., et al. (2007). The SRA 
protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to 
methylated DNA. Nature 450, 908-912. 
Shen, L., Wu, H., Diep, D., Yamaguchi, S., D'Alessio, A. C., Fung, H. L., Zhang, K., 
Zhang, Y. (2013). Genome-wide analysis reveals TET- and TDG-
dependent 5-methylcytosine oxidation dynamics. Cell 153, 692-706. 
Smallwood, S. A., Kelsey, G. (2012). De novo DNA methylation: a germ cell 
perspective. Trends Genet. 28, 33-42. 
Song, C. X., Szulwach, K. E., Dai, Q., Fu, Y., Mao, S. Q., Lin, L., Street, C., Li, Y., 
Poidevin, M., Wu, H., et al. (2013). Genome-wide profiling of 5-
formylcytosine reveals its roles in epigenetic priming. Cell 153, 678-691. 
35 
 
Sorek, R., Kunin, V., Hugenholtz, P. (2008). CRISPR—a widespread system that 
provides acquired resistance against phages in bacteria and archaea. Nat. 
Rev. Microbiol. 6, 181-186. 
Stivers, J. T., Jiang, Y. L. (2003). A mechanistic perspective on the chemistry of DNA 
repair glycosylases. Chem. Rev. 103, 2729-2759. 
Streubel, J., Blucher, C., Landgraf, A., and Boch, J. (2012). TAL effector RVD 
specificities and efficiencies. Nat. Biotechnol. 30, 593-595. 
Sung, P., Klein, H. (2006). Mechanism of homologous recombination: mediators and 
helicases take on regulatory functions. Nat. Rev. Mol. Cell Biol. 7, 739-
750. 
Szabo, P. E., Tang, S. H., Silva, F. J., Tsark, W. M., Mann, J. R. (2004). Role of CTCF 
binding sites in the Igf2/H19 imprinting control region. Mol. Cell. Biol. 24, 
4791-4800. 
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., 
Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009). Conversion 
of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by 
MLL partner TET1. Science 324, 930-935. 
Thakore, P. I., D'ippolito, A. M., Song, L., Safi, A., Shivakumar, N. K., Kabadi, A. 
M., Reddy, T. E., Crawford, G. E., Gersbach, C. A. (2015). Highly specific 
epigenome editing by CRISPR-Cas9 repressors for silencing of distal 
regulatory elements. Nat. Methods 12, 1143-1149. 




Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., Gregory, P. D. (2010). 
Genome editing with engineered zinc finger nucleases. Nat. Rev. Genet. 
11, 636-646. 
van Leeuwen, F., Wijsman, E. R., Kieft, R., van der Marel, G. A., van Boom, J. H., 
Borst, P. (1997). Localization of the modified base J in telomeric VSG 
gene expression sites of Trypanosoma brucei. Genes Dev. 11, 3232-3241. 
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., 
Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001). The 
sequence of the human genome. Science 291, 1304-1351. 
Wang, H., La Russa, M., Qi, L. S. (2016). CRISPR/Cas9 in genome editing and 
beyond. Annu. Rev. Biochem. 85, 227-264. 
Wassenegger, M. (2000). RNA-directed DNA methylation. Plant Mol. Biol. 43, 203-
220. 
Weber, A. R., Krawczyk, C., Robertson, A. B., Kusnierczyk, A., Vagbo, C. B., 
Schuermann, D., Klungland, A., Schar, P. (2016). Biochemical 
reconstitution of TET1-TDG-BER-dependent active DNA demethylation 
reveals a highly coordinated mechanism. Nat. Commun. 7, 10806. 
Wolfe, S. A., Nekludova, L., P., Carl, O. (2000). DNA recognition by Cys2His2 zinc 
finger proteins. Annu. Rev. Biophys. Biomol. Struct. 29, 183-212. 
Woo, H. R., Dittmer, T. A., Richards, E. J. (2008). Three SRA-domain 
methylcytosine-binding proteins cooperate to maintain global CpG 




Wu, H., Zhang, Y. (2014). Reversing DNA methylation: mechanisms, genomics, and 
biological functions. Cell 156, 45-68. 
Wu, S. C., Zhang, Y. (2010). Active DNA demethylation: many roads lead to Rome. 
Nat. Rev. Mol. Cell Biol. 11, 607-620. 
Xu, X., Tao, Y., Gao, X., Zhang, L., Li, X., Zou, W., Ruan, K., Wang, F., Xu, G. L., 
Hu, R. (2016). A CRISPR-based approach for targeted DNA 
demethylation. Cell Discov. 2, 16009. 
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. 
S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A. 
(2015). Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-















DEMETER plant DNA demethylase induces antiviral 













DNA methylation, a prominent epigenetic mark, usually occurs at a 
cytosine by DNA methyltransferase to add a methyl group onto 5th carbon at a 
cytosine to produce 5-methylcytosine (5mC) in both plant and animal. However, 
DNA demethylation mechanisms, the reverse process of DNA methylation, 
differentially exist in plants and animals. DNA demethylation needs to several 
enzymatic processes by stepwise in animals, whereas in plants, it is achieved by 
DNA demethylase DME which is direct excision of 5mC from DNA. In this study, I 
introduced the 5mC excision enzyme DME into human HEK-293T cells and 
observed that direct DNA demethylation activity was successfully implemented by 
DME. In addition DME induced diverse cellular response such as dysregulation of 
cell proliferation, severe DNA damage, cell cycle arrest at S phase. Gene expression 
profiling analysis revealed that DME induced diverse gene expression such as cell 
cycle component genes, heat shock proteins, and interferon stimulated genes. 
Interestingly, dsRNA triggered antiviral response by upregulation of 
retrotransposons in DME expressing cells. These results suggest that plant DNA 
demethylase DME activates the antiviral response by genotoxic stress caused by 




DNA methylation is one of the major epigenetic modification marks, adding 
a methyl group to 5-position in a cytosine by methyltransferase, associated with the 
developmental process, chromatin structure, X chromosome inactivation, genomic 
imprinting, and chromosome stability. Hypermethylation is associated with the gene 
silence, imprinting, and disease (Wu et al., 2014; Huh et al., 2008; Reik, 2007). The 
defect of DNA methylation leads to embryonic lethality in mammals and plants in 
the aberrant morphological phenotypes (Law and Jacobsen, 2010). In mammals, 
DNA methylation occurs at symmetric CG sequences and exists in ~70–80% of 
genome (Law and Jacobsen, 2010; Lister et al., 2009), whereas in plants it appears 
at the cytosine base in all sequence contexts: the symmetric CG and CHG context 
(in which H = A, T, or C) and the asymmetric CHH context. In Arabidopsis thaliana, 
genome-wide DNA methylation levels are 24% CG, 6.7% CHG, and 1.7% CHH 
context (Cokus et al., 2008), and approximately 1.5% of 5-methylcytosine (5mC) is 
present in human genomic DNA (Lister et al., 2009). 
Transposable elements (TEs) are usually suppressed by DNA methylation 
since it is able to generate mutation by the move to other sites in the genome. TEs 
comprise large parts of the human genome (~40%), and divided to two major classes: 
DNA transposons and retrotransposons. DNA transposons comprise 3% of the 
human genome and insert into new genomic sites by themselves but are currently 
inactivated. Retrotransposons, the other class of TEs, are still active in the human 
genome and inserted into new genomic sites through reverse transcription of RNA. 
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Almost all retrotransposons have a reverse-transcriptase encoding sequence, except 
the short interspersed nuclear elements (SINEs). Retrotransposons are composed of 
two groups, with absence or presence of long terminal repeats (LTRs). Human LTR 
elements are endogenous retroviruses (HERVs), and they comprise ~8% of the 
human genome. In addition, non-LTR retrotransposons are LINE-1 (long 
interspersed elements, also known as L1) and SINEs (include Alu and SVA elements); 
they comprise ~30% of the human genome (Slotkin and Martienssen, 2007; Cordaux 
and Batzer, 2009). 
DNA demethylation is the reverse process of DNA methylation, which is 
referred to as a removal of 5mC from DNA. It is essential for imprinting and for 
many developmental processes in both plants and mammals (Wu et al., 2014; Reik, 
2007; Gehring et al., 2009). DNA demethylation may occur in two different ways, 
passive and active mechanisms. Passive DNA demethylation takes place during 
DNA replication in the absence of maintenance DNA methylation, whereas active 
DNA demethylation directly removes 5mC from DNA independently of DNA (Wu 
et al., 2014; Huh et al., 2008; Reik, 2007; Law and Jacobsen, 2010). 
Recent reports show that passive DNA demethylation induces cellular 
response of innate antiviral response (Chiappinelli et al., 2015; Roulois et al., 2015). 
The intracellular antiviral response is initiated by the recognition of dsRNA from 
replication of infected viruses or viral RNA genomes. dsRNA is recognized by 
cytoplasmic RNA helicase RIG-I (retinoic acid-induced gene-I, also known as 
DDX58) and MDA5 (melanoma differentiation-associated gene-5, also known as 
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III); they have contained amino-terminal caspase activation and recruitment domains 
(CARD) and carboxyl-terminal DExD/H RNA helicase motifs (Yoneyama et al., 
2004; Takeuchi and Akira, 2008). RIG-I and MDA5 interact with another CARD 
protein, mitochondrial membrane adaptor protein MAVS (also known as IPS-1, 
VISA, or Cardiff), which relays the signal cascades (Kawai et al., 2005; Seth et al., 
2005; Xu et al., 2005; Meylan et al., 2005). This signal produces type I IFNs by 
activating the transcription factors interferon regulatory factor 3 (IRF-3), interferon 
regulatory factor 7 (IRF-7), and nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-κB) through phosphorylation (Kawai et al., 2005; Takeuchi 
and Akira, 2008; Fensterl and Sen, 2009). 
In plants, active DNA demethylation is achieved by 5mC DNA 
glycosylases combination with the base excision repair (BER) pathway. BER 
pathway is essential to repair damaged DNA or mismatched bases, which is initiated 
by DNA glycosylases. Arabidopsis DEMETER family (DME, ROS1, DML2 and 
DML3) proteins are DNA glycosylases that directly remove 5mC to create abasic 
sites (Gehring et al., 2006; Penterman et al., 2007). After 5mC excision, BER 
pathway enzymes are catalyzed to repair abasic sites subsequently by replacement 
with cytosine (Gehring et al., 2009b). Specifically, DEMETER (DME) is a 
bifunctional DNA glycosylase/AP-lyases imprinting gene (Gehring et al., 2006; 
2009a). It is expressed in the central cell of female gametophyte (Choi et al., 2002) 
and required for expressions of maternal allele-specific imprinting genes, such as 
MEDEA (MEA), FLOWERING WAGENINGEN (FWA) and FERTILIZATION 
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INDEPENDENT SEED 2 (FIS2) (Huh et al., 2008; Law and Jacobsen, 2010; 
Gehring et al., 2006; 2009a). In addition, it facilitates genome-wide demethylation 
in the endosperm (Gehring et al., 2009a). In addition, DME is expressed in pollen 
and required for demethylation of MEA, FWA, and Mu1a transposon (Schoft et al., 
2011). Other genes of the DME family are expressed in vegetative tissue, and they 
protect DNA from inappropriate DNA methylation (Gong et al., 2002; Ortega-
Galisteo et al., 2008). 
In mammals, the active DNA demethylation pathway is divided into two 
main distinct enzyme activities: 5mC hydroxylation by Ten-eleven translocation 
(TET) family proteins and deamination by the AID/APOBEC family through the 
BER pathway (Bhutani et al., 2011; Wu et al., 2014). Tet family enzymes are 
required for the hydroxylation from 5mC to 5-hydroxymethylcytosine (5hmC) and 
needed for further oxidation of 5hmC to 5-formylcytosine (5fC) and 5-
carboxycytosine (5caC) (Ito et al., 2011; Guo et al., 2011). The AID/APOBEC 
family can deaminate from 5mC to 5hmC, and 5hmC to 5-methyluracil (5mU) and 
5-hydroxymethyluracil (5hmU) respectively (Cortellino et al., 2011). TDG (thymine 
DNA glycosylase) and SMUG1 (single-strand selective monofunctional uracil-DNA 
glycosylase 1) are required for elimination of 5mU, 5hmU and 5caC. The abasic sites, 
the products of TDG/SUMG1, are replaced by cytosine via the BER pathway 
(Cortellino et al., 2011; He et al., 2011).  
The active DNA demethylation in mammals requires many enzymes for 
each step, whereas in plants, DME families directly remove 5mC, which is a more 
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simple and efficient mechanism than that in mammals. The active DNA 
demethylation of plants is a unique system through direct recognition and removal 
of 5mC by DNA glycosylases, and the homology of the DME family is absent in 
mammals. 
In this study, the function of plant specific DNA demethylase DME was 
investigated in mammals. DME was well expressed in HEK-293T cells, and it 
inhibited the association of the cell proliferation rate with DNA damage and S phase 
arrest. Gene expression profiling represented that cell cycle associated genes, 
antiviral response genes and heat shock proteins (HSPs) were differentially 
expressed without DNA methylation change in DME expressing cells. The direct 
excision of 5mC by DME in HEK-293T induced innate antiviral response genes by 




MATERIALS AND METHODS 
Cloning  
A cytomegalovirus NLS fragment was prepared by annealing the 
complementary DG104 and DG105 oligonucleotides and inserting them into the 
pEGFP C1(Clontech) vector at Bgl II and Sal I sites. DMEΔN677ΔIDR1::lnk (from 
Mok et al., 2010) was amplified by PCR (polymerase chain reaction) with primers 
DG49 and DG65. The PCR products were digested with Sal I, BamH I and cloned 
into the pEGFP C1-NLS. EGFP (from pEGFP C1 vector) was amplified by PCR 
with primers DG169 and DG194. The PCR products of EGFP were digested with 
BamH I, Not I and cloned into the pTER2hyg vector (Clontech). And NLS-
DMEΔN677ΔIDR1::lnk (from pEGFP C1-NLS-DMEΔN677ΔIDR1::lnk) was 
amplified by PCR with primers DG172 and DG173. The PCR products were 
digested with Not I, EcoR V and cloned into the pTREhyg-EGFP. EGFP-NLS-
DMEΔN677ΔIDR1::lnk (from pTREhyg- EGFP-NLS-DMEΔN677ΔIDR1::lnk) 
was amplified by PCR with primers DG392 and DG394. The PCR products were 
digested with Nhe I, Pme I and cloned into the pCDNA3.1/hygro vector 
(Invitrogen). EGFP (from pEGFP C1) was amplified by PCR with primers DG392, 
DG393 and cloned into the pCDNA3.1/hygro vector. Primer sequences were 






HEK-293T cell line was grown Dulbecco's modified Eagle's medium 
(Hyclone) supplemented with 10% fetal bovine serum (Hyclone) and 1% 
antibiotic/antimycotic solution (Hyclone) in a humidity atmosphere at 37°C and 5 % 
CO2. After cultures became 70~80% confluent (usually 3 days), cells were 
trypsinized and suspended in the fresh medium. 
 
Cell Proliferation  
2 X 105 cells were seeded on 60 mm culture dish, grown for 24 h, and 
transfected with pcDNA3.1-GFP, -DMEΔ and -DMEΔ K1286Q plasmid. 
Transfection was performed using lipofectamine 2000 reagent (Invitrogen) 
according to manufacturer’s recommendation. The medium containing the 
hygromycin B (200 μg/ml, AG Scientific) had to be replaced every 24 h. The number 
of cells was counted every 24 h after transfection using a hemocytometer for up to 
four days. 
 
GFP positive cells sorting 
5 X 105 cells were seeded on culture 60 mm dish and transfection. The cells 
were harvested 48 h after transfection, and GFP positive cells were collected using a 
FACS Aria III (BD science). The medium containing the hygromycin B (200 μg/ml, 
AG Scientific) had to be replaced every 24 h after transfection. 
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in vitro 5-methylcytosine (5mC) glycosylase activity assay 
48 h after transfection, GFP positive cells were FACS-sorted, harvested by 
centrifugation at 300 g for 5 min at 4°C, and pellet was resuspended in 100 μ L 
extraction buffer (50 mM Tis-HCl, pH 7.4, 100 mM NaCl, 10% glycerol, 0.1 mM 
dithiothreitol, complete protease inhibitor cocktail tablets; Roche). Cells were lysed 
by sonication for 2 min on ice (output power, 4; duty cycle, 50%; Branson Sonifer 
250). The lysate was centrifugation at 15000 rpm for 20 min at 4°C, the supernatant 
transferred to a new tube. The whole cell extract (10 μg) was incubated with 5`- radio 
-labeled oligonucleotide (13.3 nM) in 15 μL reaction with 10 mM Tis-HCl, pH 7.4, 
50 mM NaCl, 1 mM dithiothreitol, 0.1 mM EDTA, pH 8.0 at 37°C for 4 h. Positive 
control was used purify sumo-DMEΔN677ΔIDR1::lnk protein (50 ng). The reaction 
was terminated by adding 15 μL of stop solution (95% formamide, 20 mM EDTA, 
0.05% bromophenol blue, 0.05% xylene cyanol FF, Sigma) and boiled in water for 
5 min. Reaction products were fractionated on a 15% denaturing polyacrylamide gel 
containing 7.5 M urea and 1x Tris-Borate-EDTA buffer. Electrophoresis was done 
at 1 kV for 4 h using a CBS scientific gel apparatus. The gel was exposed to X-ray 
film (Fujifilm) at −80 °C. 
 
Cell cycle analysis and PI staining 
For the cell cycle analysis, 48 h after transfection, GFP, DMEΔ transfected 
cells were harvested by centrifugation at 300 g for 6 min. The cells resuspended 1 
mL of ice-cold 70% ethanol in PBS (phosphate-buffered saline), mixed gentle 
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agitation overnight at 4°C. The fixed cells were washed PBS and harvested by 
centrifugation. The pellets responded 0.5 mL of binding buffer (10 mM Hepes, 140 
mM NaCl, 2.5 mM CaCl2 pH 7.4), and stained with 25 µL of propidium iodide (PI; 
50 μg/mL, Sigma) and added 10 µl of RNase A (80 µg/mL, Sigma). The cells were 
incubated in dark for 30 min at room temperature, on a rocker. The PI stained cells 
were analyzed by FACS Calibur (BD science) and histograms were analyzed by 
ModFit LT (Verity Software).  
To examine the membrane integrity with PI staining, HEK-293T cells were 
seeded on poly-L-lysine (Sigma) coated cover glass in 6 well plate, grown for 24 h,  
and transfected with pcDNA3.1-GFP, -DMEΔ. 48 h after, transfected cells were 
stained with popidium iodide (8 μg/ml) for 10 min in a humidity atmosphere at 37°C 
and 5 % CO2. The cells were washed twice with 3% bovine serum albumin (BSA) 
in PBS and stained with 300 nM 4',6-diamidino-2-phenylindole (DAPI, Invitrogen) 
in 1mL of PBS for 5 min in the dark at room temperature. The cells were washed 
twice and mounted in fluorescent mounting medium (Dako). Images were acquired 
using LSM700 confocal laser scanning microscope (Carl Zeiss) and analyzed ZEN 
2009 software (Carl Zeiss). 
 
Immunofluorescence and FACS analysis of TUNEL Assay 
HEK-293T (1x105 cells/slip) cells were placed onto coated poly-L-lysine 
(sigma) cover glass in 6 well plate, incubated for 24 h, and transfected with 
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pcDNA3.1-GFP, -DMEΔ plasmid, 24 h after transfection changed the medium 
contained with hygromycin B. 48 h after transfection, the cells were fixed 100% 
methanol for 15 min at -20°C. The fixed cells were washed with 3% BSA in PBS 
and incubated with 45 μL reaction buffer (1x TdT reaction buffer, 5 mM CoCl2) for 
10 min at 37°C in a humidity chamber. The cells were then subjected to the TUNEL 
reaction with 400 U of TdT enzyme (Roche) and 20 μM BrdUTP (Invitrogen) in 50 
μL of TUNEL reaction buffer for 1 h at 37°C in humidity chamber. After three times 
consecutive washed with 3% BSA in PBS, and the cells were incubated with Alexa 
fluor 594 conjugated BrdUTP antibody (Invitrogen, B35132) in dilution buffer (5% 
bovine serum albumin, 0.3% Triton X-100 in PBS) for 1 h at the room temperature 
in dark. The cells washed again three times, and stained with DAPI (Invitrogen), and 
mounted in fluorescent mounting medium (DAKO). Images were acquired using 
LSM700 confocal laser scanning microscope (Carl Zeiss) and analyzed ZEN 2009 
software (Carl Zeiss). 
For the FACS analysis, GFP, DMEΔ transfected cells were harvested 48 
after transfection, and collected by centrifugation at 300 g for 6 min. The collected 
cells were fixed with 1 mL of ice-cold 70% ethanol in PBS, mixed gently incubation 
overnight at 4°C. The fixed cells were washed with 3% BSA in PBS by 
centrifugation at 300 g for 6 min at 4°C. The washed cells were terminal transferase 
(Roche) incubation with BrdUTP (Invitrogen) for 1 h at 37°C, and shook the cells 
every 15 min. The cells were washed with 3% BSA in PBS by centrifugation, and 
incubated with Alexa fluor 594 conjugated BrdUTP antibody (Invitrogen, B35132) 
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in dilution buffer (5% bovine serum albumin, 0.3% Triton X-100 in PBS) for 30 min 
at room temperature, protected from light and gentle agitation, and added RNase A 
(80 μg/ml, Sigma) to each cells, and incubated the cells for additional 30 min. The 
cells were washed with 3% BSA in PBS and the TUNEL positive cells were analyzed 
by FACS Calibur (BD science) and analyzed with Flowjo software (Tree Star). 
 
Western blot 
The collected GFP positive cells by FACS were lysed in lysis buffer (50 
mM Tris-HCl pH 8.0, 150 mM NaCl, 0.5% Nonidet P-40, and a complete protease 
inhibitor cocktail tablets; Roche) on ice for 30 min. The lysate was centrifugation at 
15000 rpm for 30 min at 4°C, the supernatant transferred to a new tube. The cell 
lysates were separated by electrophoresis on 10% SDS-polyacrylamide gel. The gel 
was blotted onto a Hybond C membrane (GE Healthcare). The membrane was 
blocked with TBST (20 mM Tris-HCl pH 7.4, 137 mM NaCl, 0.1% Tween-20) 
containing 3% BSA for 1 h at room temperature and then incubated with primary 
antibody solution (described below) at 4°C overnight with gentle agitation. After 
three time washing with TBST, the membrane was incubated with horseradish 
heroxidase (HRP)-conjugated secondary antibody for 1 h at room temperature. The 
signals were detected with SuperSignal West Pico Chemiluminescent Substrate 
(Thermo Scientific) and exposed X-ray film (Fujifilm). The antibodies used for 
western blotting were cyclin D1 (1:1000, SC-20044, Santa Cruz), cyclin A (1:5000, 
SC-596, Santa Cruz), cyclin B1 (1:1000, SC-245, Santa Cruz), p21 (1:500, SC-6246, 
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Santa Cruz), c-Myc (1:500, SC-746, Santa Cruz), IFN β (1:500, ab6979, abcam), 
PARP (1:1000, 9542, Cell signaling), β-actin (1:0000, sc-47778, Santa Cruz), goat 
anti-mouse IgG-HRP (1:10000, SC-2005, Santa Cruz), goat anti-rabbit IgG-HRP 
(1:10000, SC-2004, Santa Cruz). 
 
Microarray analysis 
The microarray study was carried out using Human Genome U133 Plus 2.0 
Array (Affymetrix). The GFP positive cells collected from pcDNA3.1-GFP, -DMEΔ 
plasmid transfected cells after 48 h transfection using a FACS Aria III (BD Science). 
The total RNA was isolated using a RNeasy mini kit (Qiagen) including RNase-Free 
DNase set (Qiagen), labeling and hybridization were followed by manufacturer's 
recommendation. The arrays were scanned with Affymetrix GeneChip® Scanner 
3000 7G. The data were extracted with Affymetrix Command Console1.1, and 
normalized using the MAS 5 and 50 percent present call data calculated by R affy-
package (2.11.1), DAVID software. 
 
Quantitative real time PCR analysis 
Total RNA were prepared as described in Microarray analysis section. First 
cDNA synthesis was performed using 1 μg of total RNA with used Oligo(dT) 
(Invitrogen) SuperScript III reverse transcriptase (Invitrogen), and synthesis method 
was followed by manufacturer's instruction. The synthesized first cDNA was diluted 
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to a final concentration of 30 ng/μL with nuclease-free water.  
The qRT-PCR amplification mixtures were up to 10 μL volume contained 
with 60 ng of template cDNA, Rotor-Gene SYBR Green PCR Kit (Qiagen) and 200 
nM of each gene specific forward and reverse primers. The reactions were run on at 
95°C for 10 min followed by 40-50 cycles of 94°C for 20 s, 60°C for 20 s, and 72°C 
for 30 s on a Rotor-Gene Q cycler (Qiagen). The data analysis was followed by 
previously described (Livak, K et al., 2011). The primer sequences were represented 
in Table I-2. 
 
Methylation array 
GFP-positive 293T-GFP and 293T-DMEΔ cells were isolated as described in the 
FACS analysis section. Genome-wide DNA methylation analysis was performed on 
a Human Methylation 450K BeadChip platform (Illumina) (Bibikova et al., 2011). 
Briefly, 500 ng of each gDNA sample was bisulfite-converted with the EZ DNA 
Methylation Kit (Zymo Research). 200 ng of bisulfite-converted DNA was amplified 
and hybridized onto Infinium Human Methylation 450K BeadChip (Illumina) 
according to the manufacturer’s protocol, and scanned using an Illumina iScan 
scanner (Illumina). Raw fluorescence intensity values were normalised using the 
Illumina GenomeStudio (V2011) Methylation Module. Normalised intensities were 
used to calculate β-values. The β-value represents the percentage of methylated 
cytosines at the locus, ranging from 0 (no methylation) to 1 (complete methylation). 
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Locus specific bisulfite sequencing 
The transfected cells were prepared as described in microarray analysis 
section. The genomic DNA isolation was followed by previously described 
(Aljanabi and Martinez, 1997). Bisulfite conversion of DNA was performed using 
EpiTect Fast Bisulfite Conversion Kits (Qiagen). The bisulfite converted DNA were 
amplified by PCR with bisulfite sequencing specific primers, such asIFI6, IFI44L 
and MLH3. The PCR products were cloned into the RBC T&A cloning kit (Real 
Biotech Corporation) and sequenced. The methylation patterns were analyzed by 




48 h after transfection, sorted GFP positive cells extracted total RNA used 
Trizol (Invitrogen). Five micrograms of each total RNA were electrophoresed in 1% 
(w/v) formaldehyde agarose gel and then transferred to Hybond N+ membrane (GE 
Healthcare) in a VacuGeneTM XL Vacuum Blotting System (GE Healthcare). The 
membrane was hybridization in PerfectHyb Plus Hybridization Buffer (Sigma). 
Hybridization method was followed by manufacturer's recommendation. The 
membrane was exposed to a phosphorimager screen (Fujifilm) and the radioactivity 
was measured using the Fujifilm BAS-5000 phosphorimager. Probe was prepared 
by PCR amplification at 5`UTR region of Line1 using the DG2106 and DG2107. 
PCR products were cloned into RBC T&A cloning kit (Real Biotech Corporation) 
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and digested with Hind III, Xba I. 50 nanogram probe was randomly labeled with 
random hexamers (Invitrogen), dATP, dTTP, dGTP (Invitrogen), [α-32P]dCTP 
(Perkin Elmer)  and Klenow fragment (3`→5` exo-) (New England Biolabs) at 
room temperature for 2 h. Primer sequence represented in the Table I-4. 
 
5-azacytidine treatment 
HEK-293T cells (5 X 105 cells/plate) seeded on 60 mm culture dish, grown 
for 24 h, were treated with 5-azacytidine (0, 25 μM, MP biomedicals). And the 
medium was changed 24 h after treatment contained with 5-azacytidine. The cells 
were harvested 48 h after to initiating treatment with 5-azacytidine. The collected 
cells were using following experiments, such as cell cycle analysis, qRT-PCR and 
small RNA sequencing. 
 
polyinosinic:polycytidylic acid (poly (I:C)) transfection 
HEK-293T cells (5 x 105 cells/plate) were seeded on a 60 mm cell culture plate, 
grown for 24 h, and then transfected with poly (I:C) (10 μg/mL, Sigma) using 
lipofectamine 2000 reagent (Invitrogen). Cells were harvested 36 h after transfection 





TAG aided sense/antisense transcript detection (TASA-TD) PCR 
 The experiment was essentially performed as previously described (Henk 
et al., 2015). Briefly, 48 h after transfection, total RNA was extracted from FACS-
sorted GFP-positive cells using Trizol (Invitrogen) and the first strand cDNA was 
synthesized. Strand-specific PCR was performed for L1, ERV-K and β-actin genes 
using TAG and gene-specific sense and antisense primers. Quantitation of PCR 
products were performed using ImageJ (http://imagej.nih.gov). Primer sequences for 
TASA-TD PCR are provided in Table I-5. 
 
Small RNA sequencing 
The cells were harvested 48 h after transfection or 5-azacytidine treatment. 
The total RNA was isolated from GFP, DMEΔ transfected cells or 5-azacytidine 
treated cells by the TRIzol reagent (Life Technologies) according to the 
manufacturer’s protocol. MicroRNA libraries were prepared using the TruSeq Small 
RNA Sample Preparation kits (Illumina) according to the manufacturer’s instructions. 
50 base pair single end sequencing was performed on an Illumina HiSeq 2000 system. 
The cleaned reads were generated from removing the adaptor from the raw data. And 
the differential expression of miRNA were analyzed from the cleaned reads using 










Name Sequence (5` to 3`) Note 
DG49 aattgtcgactacaaaggagatggtgcac Sal I site underlined 
DG65 aattggatccttaggttttgttgttcttc BamH I site underlined 
DG104 aattagatctccaaagaaaaagcgaaaggtaggtgtcgacaatt Bgl II, Sal I sites underlined 
DG105 aattgtcgacacctacctttcgctttttctttggagatctaatt Sal I, Bgl II sites underlined 
DG392 aattgctagccgccaccatggtgagcaaggg Nhe I site underlined 
DG393 aattgtttaaacttatctagatccggtggatc Pme I site underlined 
DG394 aattgtttaaacttaggttttgttgttcttc Pme I site underlined 
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Table I-2. Lis of the primers for qRT-PCR analysis. 
 
 
Gene Forward sequence (5` to 3`) Reverse sequence (5` to 3`) 
Cyclin D1 aactacctggaccgcttcct ccacttgagcttgttcacca 
Cyclin B1 ataaagcttgtggccccttt tcaattggatccccaggtaa 
Cyclin A2 ctggtggtctgtgttctgtga tcttggatgccagtcttactca 
Cyclin E1 ccatcatgccgagggagc ggtcacgtttgccttcctct 
p21 atgaaattcaccccctttcc aggtgaggggactccaaagt 
CDK1 ggtcaagtggtagccatgaaa ccaggagggatagaatccaa 
c-Myc tcaagaggcgaacacacaac ggccttttcattgttttcca 
Rig-1 gttgtccccatgctgttctt gcaagtcttacatggcagca 
MDA5 accaaatacaggagccatgc gcgatttccttcttttgcag 
IFIT1 tctgcaaagtcccttttgct ggggtgctctgtggtaagaa 
IFIT2 tgctgaaagggagctgaaat gacccagcaattcaggtgtt 
IFIT3 gggcagactctcagatgctc cagttgtgtccacccttcct 
IFI6 cagcagcgtcgtcataggta ggccaagaaggaagaagagg 
IFITM2 ccgtgaagtctagggacagg tgggatgatgatgagcagaa 
IFI44L tgttggcaaaagtgaagcaa gggtccagttccaaatctga 
CCR6 ggctgcaaatttgggtaaaa cacaggagaagcctgaggac 
Fas tgtcatgaacccatgtttgc gctgccatttgtagcaggtt 
MLH3 ttgcattcattagcgtctgc agggcctgttcttcaggatt 
HSPA6 aggagatctcgtccatggtg cgctgcgagtcattgaaata 
HSPA1A aggccaacaagatcaccatc tcgtcctccgctttgtactt 
DNAJB1 ttccccagacatcaagaacc ccctctcatggtccacaact 
HSPA2  aaaggtcgtctgagcaagga ataggactccagggcgtttt 
HSPB1 gagactgccgccaagtaaag tttgacaggtggttgctttg 
HSPH1 cacagccccaggtacaaact tttgctttgtcagcatctgg 
ISG15 caccgtgttcatgaatctgc ctttatttccggcccttgat 
OAS3 gtcaaacccaagccacaagt tgtaggcacacctggtggta 
CDC25C gaacaggccaagactgaagc gcccctggttagaatcttcc 
IFN β cattacctgaaggccaagga cagcatctgctggttgaaga 
IRF7 gcctggccaccataaaagc gcgcacacatgaagtcacag 
ENV tcacatggtaagcgggatgtc cgcactattggccacacattc 
3`UTR agggaaaaaccgccttaggg agcagacaaacatgtgaacaaagg 
GAPDH gagtcaacggatttggtcgt gacaagcttcccgttctcag 
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Table I-3. List of the primers for bisulfite sequencing analysis. 
 
Table I-4. List of the primers for northern blot probe. 
 
 




Gene   Forward sequence (5` to 3`) Reverse sequence (5` to 3`) 
IFI44L  aaaatttaatttaattaaaaatttgtaagg accaaacctatctacactaaaac 
IFI6  agggggagttggtgattaggttttattaa ctaactttttatcatcacttataaatcc 
MLH3  ggggagatttaagttagtgaagagag aaactatctaactcaactctttt 
Name Sequence (5` to 3`) Note 
DG2106 cctccggtctacagctcccagcgtgag Line 1 probe forward 
DG2107 ccacttgaggaggcagtctgccc Line 1 probe reverse 
Name Sequence (5` to 3`) 
Line 1 forward TAG gcacacgacgacagacgacgcacccacttgaggaggcagtctgccc 
Line 1 reverse TAG gcacacgacgacagacgacgcaccctccggtctacagctcccagcgtga
Line 1 forward  cctccggtctacagctcccagcgtgag 
Line 1 reverse  ccacttgaggaggcagtctgccc 
HERV-K forward TAG gcacacgacgacagacgacgcacacaaaaccgccatcgtcatc 
HERV-K reverse TAG acaaaaccgccatcgtcatccatggtaagcgggatgtcact 
HERV-K forward  catggtaagcgggatgtcact 
HERV-K reverse  acaaaaccgccatcgtcatc 
β-actin forward TAG gcacacgacgacagacgacgcaccaaacatgatctgggtcatcttctc 
β-actin reverse TAG gcacacgacgacagacgacgcacgctcgtcgtcgacaacggctccggca 
ß-actin forward gctcgtcgtcgacaacggctccggca 





In vitro activity of DME expressed in mammalian cells 
DNA demethylation in mammals requires successive base conversion of 
5mC prior to its removal, whereas in plants it utilizes 5mC DNA glycosylases (DNA 
demethylases) for its direct removal (Fig. I-1). A previous report showed that the 
engineered DME (DMEΔN677ΔIDR1::lnk) contained essential modules for 5mC 
glycosylase activity. The nuclear localization signal (NLS) was located at the 
deletion region of engineered DME; thus, it could not enter into the nucleus. The 
GFP and NLS were combined at the N-terminus of the engineered DME for the 
reporter and nuclear localization; these constructs are hereafter called “DMEΔ” (Fig. 
I-2). An empty vector containing GFP was used as a control. The DMEΔ was 
detected in the nucleus, whereas GFP was located at cytosol in HEK-293T cells (Fig. 
I-3). 
The first step is to identify the catalytic activity of DMEΔ in mammalian 
cells. DME can be inactivated when it is expressed in mammalian cells as a foreign 
gene. To investigate the catalytic activity of DMEΔ, I used whole cell extract. GFP 
positive cells were collected from GFAP- and DMEΔ transformants (called 293T-
GFP, DMEΔ hereafter) after 48 h transfection by flow cytometry. The whole cell 
extract of 293T-DMEΔ cells exhibited 5mC excision activity from a double-stranded 
methylated oligonucleotide in vitro, whereas the whole cell extract of 293T-GFP 
cells did not display 5mC excision activity (Fig. I-4). This result suggests that 
expression of Arabidopsis DNA demethylase DME might be able to maintain the 
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Figure. I-1. Active DNA demethylation pathways in plants and animals. In plants, 
DME/ROS1 family DNA demethylase recognizes and excises 5mC from DNA, 
forming a nick, which is then repaired through the BER and eventually replaced with 
unmethylated C. In animals, 5mC is successively converted to 5hmC, 5fC, and 5caC 
by TET enzymes prior to base excision. TDG is responsible for excision of 5fC or 
5caC producing an abasic (AP) site, which is repaired and replaced with C through 
the BER. Alternative routes may include conversions of 5mC and 5hmC into T and 





Figure. I-2. Schematic representation of the GFP-DMEΔ fragment expressed in 
HEK-293T cells. IDR2, interdomain region 2 between the glycosylase domain and 








Figure. I-3. Subcellular localizations of GFP and GFP-DMEΔ proteins in HEK-
293T cells. GFP fluorescence signals (green) indicate subcellular localizations of 
GFP and GFP-DMEΔ proteins. DAPI (blue) signals indicate nuclei. Images were 












Figure. I-4. The 5mC excision activity of the whole cell extract (WCE) of the 
293T-DMEΔ cells. The whole cell extract of the 293T-DMEΔ directly removed the 
5mC from a double-stranded methylated oligonucleotide in vitro. A purified SUMO-
DMEΔ protein was used as a positive control. The 35-mer oligonucleotide substrate 
containing 5mC at position 18 (S) and 5mC excision products (P) are indicated to 





DMEΔ is detrimental to cell proliferation in mammalian cells  
A previous report showed that DME-expressing cells declined the colony 
formation in E. coli. This was probably due to excessive excision of 5mC by DME, 
which caused DNA damage through strand break formation (Gehring et al., 2006; 
Mok et al., 2010). I investigated cytotoxicity of 293T-DMEΔ cells by observing the 
cell growth rates. 293T-DMEΔ cells represented stagnation of cell proliferation in 
comparison with 293T-GFP cells or catalytically inactive-form DMEΔ (K1286Q) 
(Mok et al., 2010) (Fig. I-5a). In addition, cell proliferation was compared between 
active DNA demethylase and the passive DNA demethylation reagent (i.e. DNMT 
inhibitor 5-azacytidine (5aza)). A similar reduction was detected when 5aza was 
treated in HEK-293T cells (Fig. I-5b). These observations suggest that abrupt DNA 
demethylation events, regardless of active or passive modes, have a negative effect 
of cell proliferation. Moreover, the 5aza-treated 293T-DMEΔ cells exhibited a more 
severe reduction in cell proliferation rate, indicating that DME expression and 5aza 




Figure. I-5. DMEΔ inhibits cell proliferation. (a) Cell proliferation rates of the 
293T-GFP, 293T-DMEΔ and 293T-DMEΔ(K1286Q) cells after transfection. 
DMEΔ(K1286Q) is a catalytically inactive fragment and was used as a negative 
control (Mok et al., 2010). (b) Cell proliferation rates of the 293T-GFP and 293T-
DMEΔ cells in the presence or absence of 25 μM 5aza in the culture medium. Error 





Direct 5mC excision induces DNA damage  
As a bifunctional DNA glycosylase, DME catalyzes both 5mC excision 
and a strand cleavage, producing 3'-phosphor-α, β-unsaturated aldehyde (3’-PUA), 
and 3'-phosphate by successive β- and δ-elimination reactions, respectively (Lee et 
al., 2014; Li et al., 2015; Martinez-Macias et al., 2012). Such lesions are intrinsically 
accompanied with DNA strand breaks acting as primary replication blocks 
(Caldecott, 2008). It suggested that expression of DMEΔ in mammalian cells were 
sufficient to make abasic sites through excessive excision of 5mC and that BER 
enzymes would not be able to repair all abasic sites. To test the abasic sites levels in 
293T-DMEΔ cells by terminal deoxynucleotidyl transferase dUTP nick end labeling 
(TUNEL) assay. 293T-DMEΔ cells were represented the abasic sites by 
immunofluorescence TUNEL assay (Fig. I-6a). Moreover, TUNEL positive cells 
were detected in 293T-DMEΔ cells about threefold more than in 293T-GFP cells by 
flow cytometry analysis (Fig. I-6b). According to a previous report, DME preferred 
excision of 5mC at the hemimethylated site more than at the full methylation site 
(Gehring et al., 2006). These results suggest that the formation of single strand 
breaks by DME DNA glycosylase and lyase activities during 5mC excision and that 







Figure. I-6. DMEΔ cause DNA damage in HEK 293T cells. ((a) TUNEL assays in 
the 293T-GFP and 293T-DMEΔ cells 48 h after transfection showed GFP protein 
(green), BrdUTP (red), and nucleus (blue). Scale bar = 10 μm. (b) Fractions of 
TUNEL-positive cells were represented in 293T-DMEΔ cells three times more than 
in 293T-GFP cells by flow cytometry analysis. TUNEL-positive cells were detected 
with Alexa fluor 594-conjugated BrdUTP antibody. Samples were analyzed 48 h 





Excessive excision of 5mC generate cell death in mammalian cells 
293T-DMEΔ cells displayed DNA damage (Fig. I-6) and reduction of cell 
proliferation; these phenomena were associated cell death. Notably, DNA damage is 
a cause of cell death. The cell death is separated morphologically into two distinct 
types: apoptosis and necrosis. Typical characteristics of apoptosis are cell shrinkage, 
plasma membrane blebbing, nuclear condensation, and DNA fragmentation 
(Suzanne and Steller, 2013). Moreover, one of the apoptosis hallmarks is cleavage 
of poly [ADP-ribose] polymerase 1 (PARP1) by caspases (Chaitanya et al., 2010). 
These apoptosis characteristics did not manifest in 293T-DMEΔ cells (Fig. I-7a, b). 
On the other hand, 293T-DMEΔ cells were stained by membrane-impermeant dye 
propidium iodide (PI) (Fig. I-7c), which was generally observed in necrosis cells 
(Unal Cevik and Dalkara, 2003; Kono and Rock, 2008). These findings suggest that 
plant DNA demethylase induces DNA damage in mammalian cells, leading to non-






Figure. I-7. Analysis of apoptosis signal in 293T-GFP and 293T-DMEΔ cells. 
PARP cleavage (a) and gDNA fragmentation (b) did not appear in either 293T-GFP 
and 293T-DMEΔ cells. Ten micro grams of each gDNA electrophoresed 0.8% 
agarose gel. (c) Popidium iodide (PI) staining of the 293T-GFP and 293T-DMEΔ 
cells showed PI (red), GFP protein (green) and nucleus (blue). Samples were 
collected 48 h after transfection. Scale bar = 20 μm..  
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 Gene expression profile analysis of DMEΔ-expressing cells 
Aberrant DNA methylation is often associated with changes in gene 
expression. DME induces gene expression by 5mC excision for the target genes in 
Arabidopsis (Huh et al., 2008). To investigate the differential gene expression by 
DME in HEK-293T cells, GFP positive cells were separated from 293T-GFP and 
293T-DMEΔ cells 48 h after transfection by fluorescence-activated cell sorting 
(FACS). Total RNA was isolated in each GFP positive cell and hybridized by Human 
Genome U133 Plus 2.0 Array. From three independent biological replications, 
compared to the 293T-GFP control, a total of 155 genes were upregulated and 42 
genes downregulated in the 293T-DMEΔ cells (≥ 2-fold, p ≤ 0.05) (Fig. I-8). Gene 
expression profiling represented cell cycle relation genes, heat shock proteins (HPSs) 






Figure. I-8. Hierarchical clustering of differential gene expression profiling in 
293T-GFP and 293T-DMEΔ cells. 155 genes were up-regulated and 42 genes down-
regulated in 293T-DMEΔ cells compared to 293T-GFP cells (≥ 2-fold, p ≤ 0.05). 
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The DNA methylation levels were maintained in 293T-DMEΔ cells 
Usually, the DNA methylation level in the promoter region is closely 
related to the expression of the gene. A total of 155 genes were upregulated in 293T-
DME cells, suggesting that there may be genes whose expression was increased by 
DNA demethylation through DME. To investigate the relationship between the DNA 
demethylation and gene expression, I compared the genome-wide DNA methylation 
patterns of 293T-GFP and 293T-DMEΔ using a Human Methylation 450K Bead Chip 
array. Genome-wide DNA methylation profiles between 293T-GFP and 293T-DMEΔ 
cells were highly similar to each other, indicating that DME expression did not 
induce substantial DNA demethylation in HEK-293T cells (Fig. I-9). In addition, 
DNA methylation levels of the promoter regions of the three genes, whose 
expression levels were increased in the gene expression profile, were investigated 
through locus-specific bisulfite sequencing. As a result, DNA methylation levels of 
three genes were represented as hypo-, intermediate-, and hypermethylated in the 
293T-DMEΔ cells. (IFI6, IFI44L, and MLH3, respectively; Fig. I-10). These results 
suggest that the up-regulated genes of 293T-DMEΔ cells were not directly increased 





Figure. I-9. DNA Methylation levels were compared between 293T-GFP and 
293T-DMEΔ cells. Frequencies of the genes with different DNA methylation levels 
(a), and scatter plot analysis of global DNA methylation levels (b) in the 293T-GFP 
versus the 293T-DMEΔ cells obtained from an Infinium Human Methylation 450K 









Figure. I-10. DNA methylation analysis by locus specific bisulfite sequencing in 
293T-GFP and 293T-DMEΔ cells. Promoter region of IFI6 (-301 ~ +9) (a), IFI44L 
(-485 ~ +23) (b), and MLH3 (-775 ~ -387) (c) as representative hypo-, intermediate, 
and hypermethylated genes, respectively. Closed circle, methylated cytosine; open 
circle, unmethylated cytosine. The 293T-GFP and 293T-DMEΔ cells were harvested 




Upregulation of heat shock proteins  
Many Hsps are upregulated in response to a variety of stress stimuli 
including DNA damage (Duan et al., 2014; Niu et al., 2006), and I observed a 
substantial increase in the expression levels of diverse Hsp genes in 293T-DMEΔ 
cells (Table I-4 and Fig. I-11). In particular, genes encoding Hsp70s (HSPA6, 
HSPA1A, and HSPA2), Hsp40 (DNAJB1) and Hsp27 (HSPB1) were highly 
expressed (> 3.5 fold) in 293T-DMEΔ cells. Hsps are known to be induced by various 
stresses, such as thermal stress, UV, reactive oxygen species (ROS) (Feder & 
Hofmann, 1999). It is notable that both Hsp70s and Hsp27s are stress-inducible and 
known to play an important role in protecting mammalian cells against DNA damage 
(Samali and Orrenius, 1998; Duan et al., 2014; Niu et al., 2006). 
 Although the detailed mechanisms by which Hsps mediate DNA damage 
signals are still elusive, these findings suggest that harmful DNA lesions associated 
with active DNA demethylation by DME may trigger heat shock response as well as 
the inhibition of apoptosis partly because of their antiapoptotic function (Kennedy 








Figure. I-11. Validation of heat shock proteins gene expression levels by 
quantitative real time PCR. The 293T-GFP and 293T-DMEΔ cells were harvested 







DMEΔ induced a cell cycle arrest at S phase  
Stagnation of cell proliferation in 293T-DMEΔ cells, suggesting there 
would be a problem in cell cycle progression. In addition, the S phase, during which 
DNA synthesis occurs, is highly sensitive to genotoxic DNA damage. Cell cycle 
progression was inspected 48 h after transfection. 293T-DMEΔ cells G1-, and G2/M-
phase decreased about 25% and, 45%, respectively, whereas S phase increased about 
30% more than 293T-GFP cells (Fig. I-12). It is plausible that DME DNA 
demethylase generates damage signals that lead to the checkpoint activation and the 
inhibition of cell cycle progression, and eventually restrict cell proliferation with S 
phase arrest (Fig. I-12). This can be partly explained by the production of excessive 
abasic sites and single strand-breaks, as both serve as primary replication blocks 
preventing DNA synthesis (Caldecott, 2008). 
DME expression may induce a change in the abundance of essential cell 
cycle regulators or factors that are key to cycle management. Cyclin D1 and Myc 
were decreased in the transcription level, while increases of cyclin B1 and p21 were 
observed in 293T-DMEΔ, whereas cyclin A2 and cyclin E were expressed at almost 
the similar level in both 293T-GFP and 293T-DMEΔ cells (Fig. I-13a, b). The protein 
levels of cyclin D1 and Myc were dramatically decreased in 293T-DMEΔ cells. The 
level of CDK1 expression was slightly higher in 293T-DMEΔ cells.  
Specifically, cell cycle negative regulator p21 was increased in 293T-
DMEΔ cells (Abbas and Dutta, 2009; Fig. I-13a, b). Tumor suppressor p53 is mainly 
a trans-acting element of p21; it is stimulated by DNA damage (Gartel et al., 1999). 
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293T-DMEΔ cells displayed DNA damage by TUNEL assay (Fig. I-6) whereas p53 
was not altered; this is because p53 and retinoblastoma protein (also known as RB) 
were inactivated in HEK-293T cells by SV40 large T antigen. Additionally, p53 
negative regulator MDM2 was enhanced in 293T-DMEΔ cells (Table I-4), 
suggesting that p21 was upregulated by a p53 independent pathway. p21 expression 
was interfered by Myc (also known as c-Myc) binding to Miz1, which is a 
transcription factor of p21 (Wu et al., 2003). 293T-DMEΔ cells showed the decrease 
of Myc; therefore, the expression level of p21 increased. Moreover, p21 was one of 
the transacting elements of cyclin B1 (Porter et al., 2003), and it could induce cyclin 
B1 expression in 293T-DMEΔ cells. 
CCND1 (also known as Cyclin D1) is an essential molecule for cell cycle 
progression. It is synthesized during G1 phase and required for G1/S phase transition 
(Baldin et al., 1993) In addition, cyclin D1 is not essential for cell proliferation 
lacking the RB in tumor cells and it is required for DNA repair (Jirawatnotai et al., 
2011) ; in addition, degradation of cyclin D1 prevents genome instability in 
genotoxic stress (Pontano et al., 2008). Reduction of cyclin D1 (Fig. I-13a, b) was 
considered important in DNA repair rather than playing a critical role in cell 





Figure. I-12. S phase arrest of the cell cycle in 293T-DMEΔ. Cell cycle 
progression of 293T-GFP (a) and 293T-DMEΔ cells (b). G1 and G2/M phase 
decreased, whereas S-phase increased in 293T-DMEΔ cells. The DNA content 
determined by flow cytometry (FL2-A). Cells were analyzed 48 h after transfection. 
The proportion of DNA at S phase was calculated using the ModFit LT version 3.0 






Figure. I-13. Validation of cell cycle components genes expression levels. 
Quantitative RT-PCR analysis (a) and western blot (b) analysis of cell cycle 
regulation genes in 293T-GFP and 293T-DMEΔ cells. Cyclin D1 and c-Myc were 
decreased, whereas cyclin B1 and p21 were increased in 293T-DMEΔ cells. Cyclin 
A was similar in both cells. β-actin was analyzed as a loading control. The 293T-GFP 
and 293T-DMEΔ cells were harvested 48 h after transfection. Error bars represent 




Interferon stimulated genes were elevated by DME 
Interferon stimulated genes (ISGs) were upregulated in 293T-DMEΔ cells 
such as IFNα-inducible protein 6 (IFI6), IFN-induced protein 44-like (IFI44L), IFI 
with tetratricopeptide repeats 1 (IFIT1), IFIT2, IFIT3, IFI transmembrane protein 2 
(IFITM2), ISG15, 2’-5’-oligoadenylate synthase 3 (OAS3), and RIG-I (Table I-1, 
Fig. II-1); MDA5 was also increased (Fig. I-14). 
RIG-1 and MDA5 comprise two caspase activation recruitment domains 
(CARDs) and DExD⁄H box helicase domain. RIG-1 detects the short dsRNA, 5` 
triphosphate group of RNA, blunt end of dsRNA and single-strand RNA hairpin, 
while the internal region of long dsRNA is detected by MDA5 (Luo et al., 2011, Wu 
et al.,2013). Rig-1 and MDA5 activated by dsRNA initiate the signal transduction of 
interferon β production (Kawai et al., 2005; Xu et al., 2005). The canonical-type I 
IFN signaling induces the expression of a number of ISGs responsible for 
establishing the cellular antiviral state (MacMicking, 2012). Interestingly, many of 
the ISGs induced by DME are implicated in RNA processing. For example, IFIT 
family genes are induced by viral RNA for translation inhibition of viral mRNA 
(Diamond and Farzan, 2013). OAS3 is responsible for degrading viral RNAs by 
activating RNase L (Hovanessian, 2007). Activated RNase L produces the small 
dsRNA through cleavage of the single-strand region of viral or cellular RNA. The 
products of dsRNA from RNase L activate the IFN-β production signal transduction 
through RIG-1 and MDA5 (Malathi et al., 2007). In addition, RNase L leads to 
decreased expression level of long interspersed element-1 (LINE-1) by degradation. 
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ISG15 inhibits IRF-3 degradation and promotes transcriptional activity to assist in 






Figure. I-14. Validation of interferon-stimulated genes expression levels by 
quantitative real time PCR. The 293T-GFP and 293T-DMEΔ cells were harvested 
48 h after transfection. Error bars represent mean ±S.D. of three independent 







Type I interferons were elevated in 293T-DMEΔ cells 
Rig-1 and MDA5 transcription levels were increased in 293T-DMEΔ cells. 
These genes activate IRF3, IRF7, and NF-κB through signal cascade. Activated IRF3 
and IRF7 are accumulated homo- and heterodimers in the nuclei; these transcription 
factors were activated by phosphorylation. IRF3 is induced by constitutive 
expression, whereas IRF7 is induced by IFNs in mammalian cells. IRF3, IRF7, and 
NF-κB complex with other transcription factors directly increases IFN-β. IRF7 and 
IFN-α is enhanced by IFN-β through the Jak–Stat pathway (Loo et al., 2011).  
IFNs were not presented in the gene expression profile, even though Rig-1, 
MDA5, and ISGs were detected in 293T-DMEΔ cells. IFN-β is an autocrine and 
paracrine manner signaling molecule; thus, it is the influence on neighbor cells. 
Since FN-β is a paracrine molecule, it may be present in the growth medium of 293T-
DMEΔ cells. However, direct measurement of the extracellular matrix level of IFN-
β was difficult. To identify the expression level of IFN-β in 293T-DMEΔ cells 
through the indirect method, HEK-293T cells were cultured using the medium in 
which 293T-DMEΔ cells were grown. However, with the indirect method, IFN-β and 
ISGs expression was detected in 293T-DMEΔ cells (Fig. I-15). 
The next step is direct investigation of the IFNs expression level in 293T-
DMEΔ cells. As a result of the investigation, the amount of transcripts and proteins 
level of IFN-β were slightly enhanced at 24 h after transfection but significantly 
increased at 48 h after transfection (Fig. I-16a). In addition, the IFN-α subtypes did 
not appear at 24 h after transfection, but IFN-α2, α4, and α6 showed transcript 
87 
 
enhancement at 48 h after DMEΔ transfection (Fig. I-16b). It can be inferred that 
induction of IFN-α subtypes was induced by early expression of IFN-β because IFN-
β is a positive regulator of IFN-α subtype. Even without viral infection, dsRNA or 
dsRNA similar structure molecules will be present in 293T-DMEΔ cells, since IFN-





Figure. I-15. Validation of IFN-β and ISGs expression levels by quantitative real 
time PCR. HEK-293T cells were grown for 48 h in the medium in which 293T-GFP 
and 293T-DMEΔ cells were grown. The graphs represent the data obtained from 







Figure. I-16. Type I interferon expression levels. a) Time dependent transcripts 
level and protein amount of IFN-β in 293T-GFP and 293T-DMEΔ cells. b) IFN-α2, 
α4 and α6 expression levels in 293T-GFP and 293T-DMEΔ cells. β-actin was 
analyzed as a loading control. The 293T-GFP and 293T-DMEΔ cells were harvested 
48 h after transfection. Error bars represent mean ±S.D. of three independent 








Antiviral response activated by dsRNA from TEs  
The innate antiviral immunity signal cascade initiates by recognition of the 
viral RNA by RIG-1 and MDA5. Interestingly, an innate antiviral immunity 
mechanism was activated in 293T-DMEΔ cells, even in the absence of viral infection. 
Thus, it was inferred that viral RNA-like molecules were generated through active 
DNA demethylation by DMEΔ. TEs compose nearly 40% the human genome; they 
are silenced by epigenetic mechanisms such as DNA methylation and RNA 
interfering in somatic cells as it is a highly mutagenic fragment in the host genome 
(Slotkin and Martienssen, 2007). Specifically, active retrotransposons were 
produced by RNA polymerase II and dsRNA were possibly generated from their 
transcripts by their own reverse transcriptase. (Levin and Moran, 2011). One of the 
retrotransposons L1 is highly abundant in the human genome (~17% with >500,000 
copies). The 5`UTR of L1 has an important role for transcription initiation: the 
composition of several transcription factor binding sites and their promoter regions 
are heavily methylated and silenced (Cordaux and Batzer, 2009). I found that L1 
transcripts levels were enhanced in 293T-DMEΔ cells (Fig. I-17a). The well-known 
retrotransposons, the human retrotransposon endogenous retroviral element (HERV) 
-K, are upregulated in 293T-DMEΔ cells (Fig. I-17b). Both L1 and HERV-K 
transcripts were detected in 293T-DMEΔ cells by tag-assisted sense/antisense 
transcript detection (TASA-TD) PCR (Henke et al., 2015) (Fig. I-17c). suggesting 
that DME elevated upregulation of sense/antisense transcripts of L1 and HERV-K 
from different loci. dsRNA forming from these mRNA activated the Rig-1/MDA5 
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cytosolic RNA sensor. As a result, IFNs were increased in 293T-DMEΔ cells through 
Rig-1 and MDA5 downstream signal transduction, and ISGs were enhanced, such as 
the IFIT family, ISG15, and OAS3.  
dsRNA analog polyinosinic:polycytidylic acid (poly (I:C)) produces IFN-
β. The production of IFN-β by poly (I:C) is separated into two distinct pathways, 
such as extracellular matrix treatment through Toll-like receptor 3 (TLR3), and 
dependent on dsRNA sensor RIG-1 by ectopic expression (Li et al., 2005). The 
ectopic expression of poly (I:C) in HEK-293T cells showed enhancement of IFN-β 
levels and activation of ISGs (Fig. I-18a, b), whereas expression of the cell cycle 
components and Hsps were not significantly affected (Fig. I-18c). These results 
imply that DME triggers activation of antiviral response through dsRNA from 
retrotransposons. Moreover, differential expression of genes such as cell cycle 








Figure. I-17. Retrotransposons expression level in in 293T-GFP and 293T-
DMEΔ cells. a) Northern blot analysis for the L1 elements in 293T-GFP and 293T-
DMEΔ cells. b) Relative expression levels of ENV and 3’ UTR of ERV-K in 293T-
GFP and 293T-DMEΔ cells analysed by qRT-PCR. c) The sense/antisense transcripts 
levels of L1 elements and HERV-K in 293T-GFP and 293T-DMEΔ cells analysed by 
the TASA-TD PCR. β-actin gene were used as a control for sense-only transcription. 
The PCR products were run on the same gel. Error bars represent mean ±S.D. of 




Figure. I-18. Differential gene expression levels through Poly (I:C) transfection. 
a) The transcripts and protein amount levels of IFN-β in the HEK-293T cells 36 h 
after poly (I:C) transfection. b-c) ISGs (b), and cell cycle components and Hsps (c) 
expression levels analyzed by qRT-PCR in the HEK-293T cells 36 h after poly (I:C) 




Passive DNA demethylation leads to a cellular response similar to active DNA 
demethylation 
Active DNA demethylation occurs by enzymatic mechanisms like DME, 
whereas passive DNA demethylation occurs by inhibition of DNA methyltransferase 
during the cell replication. Significant different or similar functions between active 
and passive demethylation mechanisms were investigated based on the gene 
expression profiles of 293T-DMEΔ cells. Interestingly, treatment of 5aza for 48 h in 
HEK-293T cells showed that cycle arrest at S phase, cell cycle components genes, 
and Hsps expression patterns were similar to those of 293T-DMEΔ cells. Moreover, 
L1 elements, HERV-k, and ISGs were upregulated (Fig. I-19). A similar consequence 
has been reported by passive DNA demethylation through inhibition of DNMT1, 
where the dsRNA from ERVs induces the antiviral response (Chiappinelli et al., 2015; 
Roulois et al., 2015). These results suggest that passive and active DNA 
demethylation are stress- induction factors through DNA damage, although different 
types of DNA damage, such as single-strand breaks of DNA, are generated by DME 





Figure. I-19. Cellular response by passive DNA demethylation. a) Cell cycle 
progression of 5aza treated with HEK-293T cells analyzed by flow cytometry. 
Expression analysis of cycle component genes (b), Hsps (c) and L1 elements, HERV-
k and ISGs (d) determined by qRT-PCR analysis. Cells were harvested 48 h after 
5aza treatment HEK-293T cells. Error bars represent mean ±S.D. of three 






Plant-specific DNA glycosylase DME can directly recognize and remove 
5mC; it is a very efficient active DNA demethylation mechanism that is not found in 
the mammalian system. This chapter represented that 293T-DMEΔ cells showed 
inhibition of cell proliferation, S phase arrest, and severe DNA damage. In addition, 
the gene expression profile showed that differential expression of cell cycle 
component genes, HSPs, and antiviral immunity genes without DNA demethylation. 
Interestingly, antiviral immunity genes, usually increased by viral infection for cell 
protection, were upregulated in 293T-DMEΔ cells even in the absence of viral 
infection. These above results were the unique cellular response by DME in HEK-
293T cells whereas it was not appeared by TET1(Jin et al., 2014; Kong et al., 2016). 
The excessive excision of 5mC produced the surplus unrepaired abasic sites 
in 293T-DMEΔ cells, which would be generating the S phase arrest (Fig. I-6). DNA 
damage during DNA replication delayed progression of S phase (Bartek et al., 2004) 
and overexpression of DNA cytidine deaminase APOBEC3A caused DNA damage 
and cell cycle arrest at S phase (Landry et al., 2011). DNA methylation generate 
normally symmetrical CG site. However, DME removes 5mC at hemimethylation 
site rather than fullmethylation (Gehring et al., 2006). It can be assumed that DME 
induces single-strand breaks and it is avoided DSBs. In addition, gene expression 
profile did not represent ATM/ATR-mediated DNA DSBs association genes. 
Therefore, the DNA damage in 293T-DMEΔ cells is likely to be a single-strand break. 
Although, 5aza treated cells were showed S phase arrest similar with 293T-DMEΔ 
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cells (Fig. I-19a), but it would be due to DSBs (Kizitepe et al., 2007).  
MicroRNAs (miRNAs) are regulated by DNA methylation (Han et al., 
2007). Interestingly, mir-34 family was boosted in both 293T-DMEΔ cells and 5aza 
treatment cells (Table I-7). The mir-34 family target genes are Bcl-2, Cyclin D1, 
Cyclin E2, CDK4, CDk6, and c-Myc (Hermeking et al., 2010). DNA damage 
induced mir-34c by p53 independent pathway and it caused S phase arrest by mir-
34c mediated Myc repression (Cannell et al., 2010). Myc and cyclin D1 are degraded 
by mir-34 family, the protein levels of Myc and cyclin D1 were dramatically 
decreased in 293T-DMEΔ cells, even though mRNA were presented (Fig. I-13). Myc 
plays an important role in the regulation of DNA replication by binding to the pre-
replication complex. (Dominguez-Sola et al., 2007). To suggest, Myc inhibition was 
one of the important reasons for S phase arrest in 293T-DMEΔ cells and 5aza treated 
















5aza 25 μM/ 
5aza 0 μM 
(Fold change) 
hsa-miR-34a-5p hsa-mir-34a 1.87  7.10 
hsa-miR-34b-5p hsa-mir-34b 3.65  4.96 
hsa-miR-34c-5p hsa-mir-34c 3.82  18.12 
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This chapter showed that INF-β was induced by the Rig-1 and MDA5 signal 
cascade in 293T-DMEΔ cells, which was initiated by the recognition of dsRNA. The 
dsRNA was generated from abundant expression of L1 and HERV-K through 
excision of 5mC by DMEΔ. The dsRNA formation is divided inference into two 
ways; reverse transcription and bidirectional transcription. L1 and HERV-K have 
encoded a reverse transcriptase. Thus, the transcripts of L1 and HERV-K were 
possible to convert into dsRNA by own reverse transcriptase. In addition, 
bidirectional transcription could occur in 293T-DMEΔ cells, considering both sense 
and antisense transcripts were identified by TASA-TD PCR. The plentiful transcripts 
of L1 and HERV-K subsequently formed heterologous dsRNA, and it was to activate 
IFN signaling. The above results suggest that bidirectional transcription would have 
a greater impact on dsRNA production.  
Although DME expressing HEK-293T cells were represented that 
differential gene expression and 5mC excision activity both in vitro and vivo (Fig. I-
4, 6, Table I-4), I did not observe significant alteration of DNA methylation levels at 
any specific loci in 293T-DMEΔ cells (Fig. I-9, 10). DME did not require specific 
sequence for 5mC excision until now discovered, and the control factors of DME 
would not exist in HEK-293T cells, since it was a foreign gene and homology genes 
were not present in mammals. Therefore, DME cannot be excised specific loci of 
5mC, also, it is believed that demethylation of DNA at specific sites by transient 
expression of DME will be difficult to validate because 5mC excision is at different 
sites in each cell.  
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According to previous report, active DNA demethylation process was 
proposed in Arabidopsis that Methyl-CpG-binding protein MBD7 bonded to high 
density CG methylation region and it was physically interacting with alpha-crystallin 
domain protein IDM2, IDM3 and histone acetyltransferase IDM1. These complexes 
assist to produce DNA demethylase acceptable chromatin status (Lang et al., 2015). 
Even if similar mechanisms exist in mammalian cells, it is difficult to apply from 
plant-derived DME. The more reliable mechanism is that DME randomly excises 
5mC to activate the TEs and other genes in 293T-DMEΔ cells. DME has DNA 
binding activity at both methylated and unmethylated sites that is not required 
specific sequence (Mok et al., 2010). TEs are strongly repressed by DNA 
methylation because activated TEs are highly mutagenic such as insertion at the 
coding region, genome rearrangement, and chromosome breakage etc (Slotkin and 
Martienssen, 2007). Especially, L1 and HERVs are large occupied part of the human 
genome (Cordaux and Batzer, 2009), where DNA methylation is concentrated in that. 
Consequently, the frequent 5mC of the L1 and HERVs region is the high probability 
to be removed by DME, and they are activated.  
Aberrant DNA methylation levels are associated human disease. 
Specifically, cancer has been studied well. Both hypomethylation and 
hypermethylation are the reason of the cancer. For example, hypomethylation of the 
promoter region of IGF2, normally silent maternally imprinted gene, is increased in 
colon cancer (Kaneda and Feinberg, 2005). On the other hand, hypermethylation of 
the promoter region induced gene silencing, such as cell cycle inhibitor p16 and 
101 
 
DNA repair genes MLH1 and BRACA1. These genes are associated multiple types 
of cancers and used for biomarker of cancers (Esteller, 2007; Mulero-Navarro and 
Esteller, 2008). Abundant research has been conducted to treat cancer caused by 
DNA methylation, especially hypermethylation. DNA methyltransferase inhibitor 
5aza has already been used as a treatment for cancer. DME is also expected to be 
used for research and therapy related to DNA methylation-associated diseases.   
Most important of this study, plant specific DME directly removed 5mC in 
mammalian system. It would be very useful tool for epigenome engineering study in 
mammals. For example, epigenome editing using REPRESSOR OF SILENCING 1 
(ROS1), one of the DME family proteins, has been reported (Parrilla-Doblas et al, 
2017). ROS1 fused with DNA binding domain of yeast (GAL4) targeted in vitro 
methylated exogenous plasmid that specifically includes GAL upstream activating 
sequence (UAS). GLA4-ROS1 fusion protein promoted DNA demethylation and 
reactivation of silenced UAS downstream report gene by transiently expressed in 
HEK-293 cells. However, the previous report did not investigate about that GAL4-
ROS1 had the off-target effect such as the expression of IFN, Hsps and 
retrotransposons. For endogenous gene expression, DME and ROS1 have to add an 
editing system such as TALEs or a CRISPR/dead CRISPR-associated protein 9 
(dCas9) system. The TALEs and CRISPR/dCas9 editing systems have already been 
fused with TET1 in mammalian cells for endogenous gene expression (Maeder et al., 
2013; Morita et al., 2016; Xu et al., 2016). If DME is used for epigenome editing, 
the off-target effect needs to be resolved. DNA binding activity of domain A in DME 
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may be stronger than the sequence-specific binding activity of TALEs or CRISPR. 
Thus, DME should be to engineer the DNA binding activity prior to use for genome 
editing. In addition, to evaluate the expression level of IFN-β, ISGs may be suitable 
markers to verify the off-target effects of TALE-DME or CRISPER-DME. DME is 
well studied and expressed in both plants and mammals, and efficiently remove 5mC 
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Reactivation of silenced genes  





The principle of genome editing is the DNA sequence modification through 
DNA cleavage with the repair process. These genome editing tools are required the 
DNA binding domain for specific locus, and it is possible to utilize for epigenome 
editing. The epigenome editing is to manipulation at the specific site of epigenome 
using the nuclease deficient genome editing systems combining with epigenetic 
modification enzymes such as DNA methyltransferase, DNA demethylase, and 
histone modification enzymes. The plant derived DNA demethylase DME, which 
directly recognizes and removes 5mC, is a superb candidate for epigenome editing. 
In this study, I examined that TALE and CRISPR/nCas9 fusion protein of DME 
activated the targeted specific gene and reduction of DNA methylation. Specifically, 
DMEΔN697+lnk, among the N-terminal truncation series of DME, activated the 
targeted gene expression and observed that DNA demethylation was induced at the 
targeted locus. This system is possible to utilize for clinical research field of DNA 





Producing genetic mutation is the best way to identify the function of genes 
underlying cellular processes. Inducing random mutations has been traditionally 
used for genetic screening by treatment with various mutagens such as ultraviolet, 
chemicals, and radiation. This mutational analysis has an intrinsic limit that 
specifically targeted mutations cannot be obtained, which necessitates a 
complicated or laborious process to find the mutated locus (Wei et al., 2013). 
Although a small interfering RNAs (siRNAs) technique enabled the silencing of 
specific genes, and it has been widely used for gene function analysis, several studies 
revealed defects in this technique, such as incomplete silencing of the target gene 
and off-target gene regulation (Krueger et al., 2007; Jackson et al., 2003). 
Researchers have sought to generate direct mutation at the specific DNA sequence, 
and genome-editing technologies have been developed through their aspirations and 
innovations.  
The programmable genome editing system is based on the fusion of the 
sequence-specific DNA-binding domain and the non-sequence-specific DNA 
cleavage domain. In eukaryotes, targeted genome editing induces DNA double-
strand breaks (DSBs) at a specific locus, which can be repaired by two distinct 
pathways: homologous repair (HR) and non-homologous end joining (NHEJ). HR 
enables the insertion of the exogenous DNA sequences at the DSB sites, whereas the 
error-prone NHEJ induces nucleotide insertions, deletions, or substitutions at the 
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target sequence. These repair pathways are required for precise manipulation of gene 
sequences (Sung and Klein, 2006; Lieber, 2010; Kim and Kim, 2014). 
The targeted genome editing technology was facilitated by the 
enhancement of the DNA-binding modules. The zinc finger (ZF) and the 
transcription activator-like effectors (TALEs) have been typically used to recognize 
the target sequence by protein-DNA interaction. ZF is the most common type of 
DNA binding motif in eukaryotes, which was found in diverse human transcription 
factors (Tupler et al., 2001). Since each Cys2-His2 zinc finger binds to 3-bp in the 
major groove of DNA, multiple zinc finger proteins should be assembled in an array 
to recognize the target sequence accurately (Gaj et al., 2013). TALEs are, other 
DNA-binding modules, derived from the plant pathogen Xanthomonas spp. TALEs 
possess tandem monomer repeats in the central DNA-binding domain, and each 
repeat contacts a single base pair in the major groove of DNA for nucleotide binding 
specificity (Boch and Bonas, 2010; Miller et al., 2011; Scholze and Boch, 2010). 
However, the initial base of the TALEs target sequence is restricted to thymine, and 
TALEs designed for thymine also recognize 5-methylcytosine due to structural 
similarity between the two bases (Boch et al., 2009; Moscou and Bogdanove, 2009; 
Scholze and Boch, 2010; Cong et al., 2012; Streubel et al., 2012; Deng et al., 2012).  
Recently, the clustered regularly interspaced short palindromic repeat 
(CRISPR)/Cas9 (CRISPR-associated) system has provided a breakthrough for 
genome editing based on RNA-DNA interaction. The CRISPR/Cas system, found in 
the E.coli genome 30 years ago (Ishino et al., 1987), is an adaptive immune system 
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in bacteria, that invades foreign target DNA via RNA-guided DNA nuclease 
(Barrangou et al., 2007; Wiedenheft et al., 2012). The CRISPR repeat arrays, 
including spacers, are transcribed and processed into small interfering CRISPR 
RNAs (crRNAs), which are required for recognition of the target sequence through 
Watson-Crick base pairing. Each crRNA is hybridized with transactivating CRISPR 
RNA (tracrRNA) and guides Cas protein to cleave complementary sequences known 
as protospacers in the invading DNA (Barrangou et al., 2007; Deltcheva et al., 2011; 
Gasiunas et al., 2012). These crRNA and the tracrRNA were fused with a chimeric 
single-guide RNA (sgRNA), which leads to the optimization of the type II CRISPR 
system (Jinek et al., 2012). The type II CRISPR system relies on a single RNA-
guided endonuclease Cas9, the most widely used form of which is from 
Streptococcus pyogenes. The target recognition by Cas9 requires the presence of a 
conserved protospacer-adjacent motif (PAM) which is usually 5’-NGG-3’ and 
located immediately at the 3’ end region of the target sequence (Jiang et al., 2013). 
Cas9 cleaves the target at the 3-nucleotide upstream site of the PAM sequence by 
two nuclease domains, HNH and RuvC. The former is responsible for the cleavage 
of the complementary DNA strand to the crRNA, and the latter cleaves the opposite 
non-complementary strand (Gasiunas et al., 2012; Jinek et al., 2012). 
ZF and TALEs have been used extensively for genome editing, but they 
have limitations. Although ZF can theoretically cover all DNA sequences, the target 
sequences are limited by context-dependent availability of the ZF domains (Sander 
et al., 2011). TALEs, due to the highly repetitive sequences, require specific 
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DNA assembly techniques, such as Golden Gate cloning. (Engler et al., 2008). 
Moreover, ZF and TALEs depend on the protein-DNA interaction, which leads to 
relatively low targeting efficiency. The CRISPR/Cas9 system, however, is more 
efficient, because it is the RNA-guided nuclease system that uses the base pairing 
with the target DNA sequence. The CRISPR/Cas9 system also has advantages over 
ZF and TALEs regarding simplicity, cost, and versatility. It can recognize and cleave 
methylated DNA where other nucleases cannot reach, and it can target multiple genes 
at the same time in a host (Cong et al., 2013; Hsu et al., 2013).  
Beyond genome editing, TALEs and the CRISPR/Cas9 systems offer 
promising approaches to the sequence-specific regulation of gene expression. TALEs 
and dCas9, a catalytically inactive Cas9 with mutations in the RuvC (D10A) and 
HNH (H840A) domains, can be fused with the catalytic domains of effectors such 
as transcription activators, transcription repressors, and histone-modifying enzymes, 
DNA methyltransferases, and DNA demethylases (Urnov et al., 2010; Gaj et al., 
2013; Wang et al., 2016). Fused with a transcription activator VP64, which is 
composed of four tandem copies of VP16 (Herpes Simplex Viral Protein 16), both 
TALEs and dCas9 can activate the expression of OCT4 (POU5F1) and VEGFA 
(Maeder et al., 2013a; Maeder et al., 2013b; Hu et al., 2014). The fusion of dCas9 
with Krüppel associated box (KRAB), a transcription repressor domain of the KOX1 
(also known as a ZNF10), can suppress the expression of the target genes (Hu et al., 
2014). In addition, dCas9 fusion with the activator core region of the human histone 
acetyltransferase p300 leads to the transcription activation of the target genes (Hilton 
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et al., 2015). The fusion proteins TALE-TET1 and dCas9-TET1 induce the 
transcriptional activation of the downstream genes as well as DNA demethylation at 
the target region through oxidation of 5mC to 5hmC followed by further oxidation 
of 5hmC to 5fC and 5caC (Maeder et al., 2013c; Wu and Zhan, 2014; Morita et al., 
2016; Xu et al., 2016). 
DNA methylation is an important epigenetic factor that regulates gene 
expression. In mammals, DNA methylation usually occurs at cytosine of CpG island 
by DNA methyltransferase, whereas DNA demethylation, the reverse process of 
DNA methylation, is achieved through oxidation of 5mC by the TET1 family or 
deamination of 5mC the by AID/APOBEC family (Wu et al., 2014; Law and 
Jacobsen, 2010). DNA demethylation of plants is accomplished by direct recognition 
and removal of 5mC by plant-specific DNA demethylase DEMETER (DME), which 
is a simpler, more efficient mechanism (Gehring et al., 2006; Mok et al., 2010).  
In this chapter, epigenome editing was performed by targeted DNA 
demethylation to reactivate silenced genes in mammalian cells. The plant-derived 
DME protein was fused with the DNA binding modules used for genome editing 
systems, such as the TALE module and the CRISPR/Cas9 system. To optimize the 
epigenome editing system, DNA binding modules (TALE, dCas9, and nCas9) and 
diverse truncated forms of DME proteins were examined. Expression of TALE-DME 
in HEK293T cells induced slight reactivation of Oct4 and targeted DNA 
demethylation in the KLF4 genomic region. Although the DME∆N677+lnk protein 
fused with the targeting module displayed an off-target effect by its own DNA 
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binding activity, DME∆N697+lnk, another truncated form that loses its DNA 
binding activity, was found to be a powerful tool for epigenome editing. Finally, 
dCas9-DME∆N697+lnk or nCas9-DME∆N697+lnk transfected cells exhibited clear 







MATERIALS AND METHODS 
Construction of TALE-DME fusion proteins  
A GFP fragment was amplified with DG392 and DG194 and cloned into 
NheI and NotI sites of the pCDNA3.1 vector (Invitrogen). Constructs of TALE 
modules targeting Oct4 were assembled by the ToolGen (Korea). The fragments of 
TALE DNA-binding domain containing a nuclear localization signal (NLS) were 
amplified with DG2121 and DG1855, digested with NotI and EcoRV sites and 
cloned into the corresponding sites of pCDNA3.1-GFP. A DME∆N677+lnk 
fragment was amplified with DG2047 and DG2048 and cloned into EcoRV and 
PmeI sites of pCDNA3.1-GFP-TALE construct to produce pCDNA3.1-GFP-
TALE-DME∆N677+lnk. 
A 3xflag fragment was prepared by annealing the complementary DG2146 
and DG2147 oligonucleotides and cloned into NheI and NotI sites of the 
pCDNA3.1 vector. TALEN constructs targeting RHOXF2 and KLF4 were obtained 
from Addgene (Meader et al., 2013, Addgene 49942) and ToolGen (Korea), 
respectively. The fragment of KL-1 TALE targeting KLF4 genomic region was 
amplified with DG2121 and DG1855 and cloned with NotI and EcoRV sites of 
pCDNA3.1-3xflag. The four truncated fragments of DME, DME∆N677+lnk, 
DME∆N687+lnk, DME∆N697+lnk, and DME∆N703+lnk, were amplified with 
forward primers, DG2612, DG2626, DG2613, DG2614 and a reverse primer, 
DG2048, respectively from constructs of the previous report (Mok et al., 2010) and 
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cloned into XbaI and PmeI sites of pCDNA3.1-3xflag-KL-1 TALE.  
 
Construction of Cas9 for in vivo DNA cleavage assay 
A multiple cloning site (MCS) was inserted into pX460 (Addgene 48873 
from Feng Zhang) at AgeI and EcoRI sites by annealing complementary DG2932 
and DG2933 oligonucleotides to produce a modified pX460 (hereafter pCbh). A 
GFP fragment was amplified with DG2912 and DG2913 and cloned into NheI and 
MluI sites of the pCbh vector to produce pCbh-GFP.  
The catalytically active Cas9 was prepared by site-directed mutagenesis 
using a pair of mutagenic primers DG3031 and DG3030 from pX460 bearing nCas9, 
a Cas9 D10A mutant. The Cas9 fragment was amplified using DG2914 and 
DG2970, and cloned into the MluI and SpeI sites of pCbh-GFP to generate pCbh-
GFP-Cas9 for in vivo DNA cleavage assay.  
 
Construction of nCas9-DMEs and dCas9-DMEs fusion proteins 
The nCas9 fragment was amplified with DG2914 and DG2919 from the 
pX460 vector, and cloned into the MluI and SpeI sites of pCbh-GFP to generate 
pCbh-GFP-nCas9. The BbsI sites in DME and TET1 sequences were removed by 
site-directed mutagenesis using mutagenic primers (TableII-1). The three truncated 
fragments, DME∆N677+lnk, DME∆N697+lnk, and DME∆N703+lnk, were 
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amplified with forward primers, DG2920, DG2964, DG2981 and a reverse primer, 
DG2048, respectively. The TET1 catalytic domain (CD) fragment was amplified 
using DG2927 and DG1034. The truncated DME and the TET1 CD fragments were 
digested with SpeI and PmeI and inserted into pCbh-GFP-nCas9. To generate 
constructs of pCbh-sgRNA(RANKL)-GFP-nCas9 fused DME∆N677+lnk, 
DME∆N697+lnk, DME∆N703+lnk, and TET1 CD, the sgRNA targeting RANKL 
was generated by annealing complementary DG2975 and DG2976 oligonucleotides 
and cloned into BbsI sites of recombinant plasmids. As a control, the pCbh-GFP-
nCas9 construct was produced using DG2914 and DG2970. 
The catalytically dead Cas9 (dCas9) containing the D10A and H840A 
mutations were prepared by site-directed mutagenesis using DG2916 and DG2917 
from the pX460 vector. To generate pCbh-GFP-dCas9, the dCas9 fragment was 
amplified with DG2914 and DG2919 from the pX460 vector, digested with MluI 
and SpeI, and cloned into the corresponding sites of pCbh-GFP. The three truncated 
fragments, DME∆N677+lnk, DME∆N697+lnk, and TET1 CD were cloned into 
SpeI and PmeI sites of pCbh-GFP-dCas9. As a control, the pCbh-GFP-dCas9 
construct was produced using DG2914 and DG2970. Primer sequences were listed 






Cell culture and Transfection 
HEK-293T cells were grown Dulbecco's modified Eagle's medium 
(DMEM, Hyclone) supplemented with 10% fetal bovine serum (FBS, Hyclone) and 
1% antibiotic/antimycotic solution (Hyclone) in a humidity atmosphere at 37°C and 
5 % CO2. 5 X 105 /4 X 105 cells were seeded on culture 60 mm dish, grown for 24 h, 
and then transfected with recombinant plasmids.  
Plasmids encoding TALE-DME fusions targeting OCT4 and KLF4 were 
transfected into cells using the Lipofectamine 2000 Reagent (Invitrogen) according 
to the manufacturer’s protocol. The DMEM medium containing 200μg/mL of 
hygromycin B (AG Scientific) was replaced 24 h after transfection and then freshly 
changed every 48 h. The transformants were obtained after 2 weeks selection with 
200ng/ml hygromycin B.  
Plasmids encoding nCas9-DME and dCas9-DME fusions with sgRNA 
targeting RANKL were transfected into cells, using the calcium phosphate co-
precipitation method. The DMEM medium was replaced 24 h after transfection. 
Cells were harvested 48 h after transfection and sorted using FACS Aria III (BD 
Bioscience) to isolate the GFP-positive cells.  
 
Quantitative real time PCR analysis 
Isolation of total RNA, first cDNA synthesis and qRT-PCR analysis were 
performed as described at Chapter 1. The primer sequences were listed in Table II-2. 
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Locus-specific bisulfite sequencing 
Isolation of genomic DNA and bisulfite conversion were performed as 
described at Chapter I. The methylation patterns were analyzed by CyMATE 
(http://www.cymate.org). The primer sequences were listed in the Table II-3. 
 
Constructs of Cas9 and TALE-DME for protein purification 
A Cas9 fragment was amplified with DG2979 and DG2970 from pCbh-
GFP-Cas9 plasmid. The fragment was digested with BamHI and SpeI and cloned 
into the corresponding sites of pBG102 expression vector.   
The fragments of KL-1 TALE-DME∆N677+lnk, KL-1 TALE-
DME∆N697+lnk and KL-1 TALE-DME∆N703+lnk were digested with NotI and 
PmeI, and cloned into the corresponding sites of the pBG102 vector. Primer 
sequences were listed in the Table II-1. 
 
Protein expression and purification  
  Recombinant plasmids expressing N-terminal 6×His-SUMO tagged Cas9, 
DME∆N677+lnk, KL-1 TALE-DME∆N677+lnk, KL-1 TALE-DME∆N697+lnk , 
KL-1 TALE-DME∆N703+lnk were transformed into Escherichia coli Rosetta2 
(DE3) strain (Novagen). Cells were grown at 28°C in four liters of LB containing 50 
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μg/ml of kanamycin and 50 μg/ml of chloramphenicol until the OD600 reached 0.4. 
Protein expression was induced with 0.1 mM IPTG at 18°C for 16 hr except for the 
6×His-SUMO-Cas9 protein which was induced with 0.2 mM IPTG at 18°C for 16. 
Cells were harvested by centrifugation at 7,500 rpm for 20 min at 4°C and 
resuspended in 30 ml of lysis buffer (50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 10% 
glycerol, 0.1 mM dithiothreitol (DTT), 0.1 mM PMSF). Cells were lysed by 
sonication for 5 min (0.5x duty cycle; Branson Sonifer 250) on ice. Cell extracts 
were centrifuged at 12,000 rpm for 30 min at 4°C and the supernatant was filtered 
through nylon membranes with 0.8 μm and 0.45 μm pore (Advantec), sequentially. 
The lysate was sequentially purified by three different types of columns: affinity 
column (HisTrap FF 5 ml, GE Healthcare) with a gradient of imidazole, ion 
exchange column (Heparin HP 5 ml, GE Healthcare) with a gradient of NaCl and 
size exclusion (HiLoad 16/60 Superdex 200-pg, GE Healthcare). The final eluted 
fractions were concentrated and aliquoted with 50% glycerol and stored in a storage 
buffer (20 mM Tris-HCl, pH 7.4, 40 mM NaCl, 4% glycerol, 20 μM DTT) at -80 °C 
until use. 
 
DNA Binding Assays 
 Oligonucleotides were synthesized from Integrated DNA Technologies. Forty 
pmol of each oligonucleotide was radiolabeled with [Ɣ-32P] ATP (6000 Ci/mmol, 
Perkin Elmer Life Sciences) using T4 polynucleotide kinase (Takara) and then 
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annealed to a complementary oligonucleotide to produce double stranded DNA 
substrates. To produce the unlabeled competitor substrates with the same 
concentration of radiolabeled substrates, 5mC-containing oligonucleotides were 
purified with the QIAquick Nucleotide Removal Kit (Qiagen) and annealed with 
complementary oligonucleotides. One hundred nanomolars of oligonucleotide 
substrate were incubated with varying amounts (100 and 200 ng) of 6×His-SUMO 
tagged DME∆N677+lnk, 6×His-SUMO tagged KL-1 TALE-DME∆N677+lnk, 
KL-1 TALE-DME∆N697+lnk, and KL-1 TALE-DME∆N703+lnk proteins in 10 
μL of binding buffer (10 mM Tris, pH 8.0, 1mM EDTA 0.4 mg⁄mL BSA) for 10 
min at 23°C.  
For DNA binding competition assay, each of 6×His-SUMO tagged KL-1 
TALE-DME∆N677+lnk and KL-1 TALE-DME∆N703+lnk proteins were incubated 
with 100 nM of radiolabeled oligonucleotides in the presence of competitor 
substrates. The amount of competitor oligonucleotides varied from 0 to 4-fold (0, 
100, 200, 400 nM) over radiolabeled substrates. The reactions were separated on a 
native polyacrylamide gel (4% acrylamide, 2.5% glycerol, 0.5X Tris-Borate-EDTA 
buffer). The gel was exposed to X-ray film at −80°C. Oligonucleotide sequences 




DNA cleavage assay in vivo and in vitro 
gDNA was extracted from the GFP-positive cells after tranfection with the 
pCbh-sgRNA(RANKL)-GFP-Cas9. The target region was amplified with DG3087 
and DG3088 (Table II-7), cloned into RBC-TA vector and sequence to confirm DNA 
mutation.  
Cas9 in vitro cleavage assay was based on the previous report. (Jinek et 
al.,2012). Brirfly, In vitro transcription template for sgRNA generation was 
amplified by PCR with DG2987 and DG2988, the PCR templated from pCbh-
sgRNA(RANKL)-GFP-Cas9. The PCR products were in vitro transcribed using 
MAXIscript T7 transcription kit (Thermo Fischer Scientific) according to 
manufacturer’s recommendation. A substrate was prepared by annealing the 
complementary RANKL sgRNA-3 F and RANKL sgRNA-3 R oligonucleotides 
(Table II-5), and A-talling with Ex taq (Takara) and inserting them into RBC-TA 
vector. To genetate linear DNA, the plasmid was digested with NdeI. For the DNA 
cleavage reaction, sumo-Cas9 (500 nM) was pre-incubated with denature sgRNA 
(500 nM) at room temperature for 5min in the cleavage reaction buffer (20 mM 
Hepes, pH 7.0, 100 mM NaCl, 5mM MgCl2) and target plasmid (100 nM) was added. 
The mixture was incubated for 2 h at 37°C. Gel electrophoresis was conducted on a 





Table II-1. List of primers for cloning. 
Name Sequence (5` to 3`)  
DG194 aattgcggccgcatctagatccggtggatc  
DG392 aattgctagccgccaccatggtgagcaaggg  
DG1034 aattgtttaaactcagacccaatggttatagggcc  
DG1855 aattgatatccaacgcggctagcgccggatc  
DG2047 aattgatatcggtggcggctcctacaaaggagatggtgcacttg  
DG2048 aattgtttaaacttaggttttgttgttcttcaatttg  
DG2121 aattgcggccgcggaattgcctccaaaaaagaagag  
DG2146 aattgctagcatggactacaaaga  
DG2147 aattgcggccgcgtcatcgtcatccttgtaatc  
DG2612 aatttctagaggtggcggctcctacaaaggagatggtgcacttg  
DG2613 aatttctagaggtggcggctccgttgacattgacgatgaaac  
DG2614 aatttctagaggtggcggctccacaactcgcatatggaac  
DG2617 aatttctagaggtggcggctccgaactgcccacctgcagctgtcttg  
DG2626 aattctagaggtggcggctccgagagcaagaagcgaaaacc  
DG2912 aattgctagcgccaccatggtgagcaagggcgaggagc  
DG2913 aattacgcgttctagatccggtggatcccggg  
DG2914 aattcgcgttggactataaggaccacgacgg  
DG2916 ccgactacgatgtggacgccatcgtgcctcagagctttctg  
DG2917 cagaaagctctgaggcacgatggcgtccacatcgtagtcgg  
DG2919 aattactagtctttttcttttttgcctggccggc  
DG2920 aattactagttacaaaggagatggtgcacttg  
DG2922 ggaagaagaaagaagagtctttcgaggaagggctgattcc  
DG2923 ggaatcagcccttcctcgaaagactcttctttcttcttcc  
DG2925 gtccgtggattcgaacagaaaacaagagcaccgcgtcc  
DG2926 ggacgcggtgctcttgttttctgttcgaatccacggac  
DG2927 aattactagtgaactgcccacctgcagctgtc  
DG2928 ggcttctcctggtccccgaaaactgcttcagccacaccag  
DG2929 ctggtgtggctgaagcagttttcggggaccaggagaagcc  
DG2930 ctgtacgatgccttcgggaaaactcagtggtgccaatgcag  
DG2931 Ctgcattggcaccactgagttttcccgaaggcatcgtacag  
DG2932 aattaccggtgctagcacgcgtgatatccacgtgactagtgtttaaacgaattca  
DG2933 aattgaattcgtttaaacactagtc  
DG2964 aattactagtgttgacattgacgatgaa ac  
DG2970 aattactagtttactttttcttttttgcctggccggc  
DG2975 caccgcaaggggagtctggaaccac  
DG2976 aaacgtggttccagactccccttgc  
DG2979 aattggatccatggactataaggaccacgacgg  
DG2981 ttactagtacaactcgcatatggaac  
DG3030 gcccacagagttggtgccgatgtccaggccgatgctgtacttcttg  




Table II-2. List of primers for qRT-PCR. 
Gene Forward sequence (5` to 3`) Reverse sequence (5` to 3`) 
OCT4 atggcgggacacctggcttcggatttcg tcagtttgaatgcatgggagagccc 
RHOXF2 ggcaagaagcatgaatgtga tgtctcctccatttggctct 
RANKL actattaatgccaccgaca agggtatgagaacttgggat 
IIFN-β cattacctgaaggccaagga cagcatctgctggttgaaga 




Table II-3. List of primers for bisulfite sequencing. 
Gene Forward sequence (5` to 3`) Reverse sequence (5` to 3`) 
KLF4 gggatagttttygtgtttttggtttagttgtgtatg actaatccctccccctccaaatccc 
OCT4-1 atttgttttttgggtagttaaaggt acctttaactacccaaaaaacaaat 
OCT4-2 ggatgttattaagatgaagatagttgg cctaaactccccttcaaaatctatt 




Table II-4. List of oligonucleotide for DNA binding assay. 
 
  
Name Sequence (5` to 3`) 
random 35M forward gtactgtgtgatactat[5mc]gaattcagtatgatctg 
random 35M reverse cagatcatactgaattcgatagtatcacacagtac 
KL-1 40M forward gtgttcagctgtgtatgcccgtggtctat[5mC]gaattcagta  
KL-1 40M reverse tactgaattcgatagaccacgggcatacacagctgaacac 
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Table II-6. List of target sequence for TALE or CRISPR/Cas9. 
Name Sequence (5` to 3`) Note 
OCT4-1 tgcccctccccctcctctga TALE 
OCT4-2 tgcatgacaaaggtgccgtg TALE 
OCT4-3 tgcaaccccactgccttgta TALE 
OCT4-4 tgtggcaggtattgaaatg TALE 
OCT4-5 tctacacagacaggagatgg TALE 
OCT4-6 tccctcaatctgccaggct TALE 
KL1 tcagctgtgtatgcccgtgg TALE 







Name Sequence (5` to 3`) 
RANKL sgRNA-3 atggcaaggggagtctggaaccactggagtagcgaattcagtatgatctc 








Expression level of OCT4 was slightly activated by TALE-DME  
Transcription factors including OCT4 and SOX2 bind to their own 
promoters and activate their expression via autoregulatory circuitry, which is 
necessary for maintenance of pluripotency in pluripotent cells. A nucleosome-
depleted region (NDR) is important for ensuring the OCT4 autoregulation loop, 
which is present at the OCT4 distal enhancer. During the differentiation, the NDR 
was lost, resulting in nucleosome occupancy and change in DNA methylation 
occurring at the OCT4 distal enhancer (You et al., 2011). The expression of OCT4 is 
suppressed in HEK-293T cells since the promoter region is heavily methylated. 
However, it is activated through DNA demethylation at the OCT4 distal enhancer 
when HEK-293T cells are treated with the whole-cell post-chromosomal supernatant 
of undifferentiated NCCIT cells, which is one of the pluripotent stem cell lines, 
human embryonic carcinoma (Freberg et al., 2007). The previous studies 
demonstrated that DNA hypomethylation at the OCT4 distal enhancer is involved in 
activation and maintenance of OCT4 expression. Thus, the OCT4 distal region was 
considered as a target region for epigenome editing by plant-specific DNA 
demethylase DME. 
A total of six TALE constructs were designed to target the promoter of 
OCT4 (Fig. II-1a); these were conjugated with an engineered DMEΔN677+lnk 
fragment consisting of the domains essential for 5mC excision. Each TALE construct 
and DMEΔN677+lnk fragment were tethered together with a short linker GGGS 
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(Gly-Gly-Gly-Ser) (Fig. II-1a, Table II-2, 3). To identify expression of TALE-DME 
fusion proteins in HEK-293T cells, a green fluorescent protein (GFP) was fused with 
the N-terminal of TALE-DME fragments (called GFP-TALE-DME hereafter) (Fig. 
II-1b). The GFP-TALE-DME fusion protein was found to be localized in the nucleus 
(Fig. II-2). The expression level of OCT4 was measured 2 weeks after 
transfection and found to be slightly increased in HEK-293T cells expressing 
GFP-TALE-DME 1-3 and 6 (Fig. II-3). To determine whether upregulation of 
OCT4 was caused by targeted DNA demethylation, DNA methylation level at each 
target region was analyzed by locus-specific bisulfite sequencing. Among the cells 
transfected with GFP-TALE-DME 1-3 and 6, GFP-TALE-DME6 induced a decrease 
in DNA methylation level at OCT4 promoter (Fig. II-4). Although DNA methylation 
levels at the target regions of OCT4 were reduced in the cells transfected with TALE-
DME 4 and 5, OCT4 expression levels did not increase. This suggests that regions 4 








Figure. II-1. Schematic representation of the target regions of TALE-DME in 
the OCT4 promoter and the TALE-DME construct. a) The six target regions of 
TALE-DME are represented in the OCT4 promoter. Closed circles indicate 
methylated cytosines and the asterisks signify the expected sites where DNA 
demethylation occurs. DE, distal enhancer; TSS, transcription start site. b) Schematic 
diagram of the fusion of GFP, TALE, and DME. NLS, nuclear localization signal; 





Figure. II-2. The expressed TALE-DME protein targeting OCT4 was localized 
in nucleus of HEK-293T cells. GFP fluorescence signals (green) indicate 
subcellular localizations of GFP proteins. Images were obtained 2 weeks after 




Figure. II-3. The expression level of OCT4 was slightly activated by TALE-DME. 
The cells transfected with six TALE-DME constructs targeting OCT4 were harvested 
2 weeks after transfection. The expression level of OCT4 was validated by 




Figure. II-4. The DNA methylation level of the OCT4 promoter region was 
slightly decreased by TALE-DME expression. Locus-specific bisulfite sequencing 
was performed for DNA methylation analysis. a-f) TALE-DME target regions 1 to 6 
in the OCT4 promoter. The cells were harvested 2 weeks after transfection. The 
asterisks signify the expected sites where DNA demethylation occurs. Closed circle, 
methylated cytosine; open circle, unmethylated cytosine.   
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KL-1 TALE-DME induced KLF4-targeted DNA demethylation  
Given that TALE-DMEs rarely induce targeted DNA demethylation at 
OCT4 distal enhancer, it was hypothesized that DNA binding activity of DME 
interrupted the sequence-specific DNA binding activity of TALEs. The elimination 
of DNA binding activity of DME is necessary for epigenome editing. It was 
previously reported that DME is composed of three essential domains (domains A 
and B and glycosylase domain), and domain A is required for DNA binding. In 
addition, the truncations of N-terminus of domain, A which possesses positive charge 
residues, exhibited a loss of DNA binding activity of DME (Mok et al., 2010). Based 
on the previous report, a series of truncations at domain A (DMEΔN687+lnk, 
DMEΔN697+lnk, and DMEΔN703+lnk) were produced. The truncation series were 
fused to KL-1 TALE, targeting the second intron of KLF4. A previous study reported 
that the KL-1 TALE-TET1 CD fusion protein induced targeted demethylation at 
KLF4. The DME truncation series fused with KL-1 TALE were generated to examine 
DNA demethylation activity. The constructs were transfected into HEK-293T cells, 
and the transformants were harvested 2 weeks after transfection. The DNA 
methylation level was slightly decreased by KL1-TALE DMEΔN697+lnk compared 
to the control, demonstrating that DNA demethylation was induced by KL-1 TALE-
mediated specific binding and was not a simple result of overexpression of DME 
truncation (Fig. II-5). These results suggest that DMEΔN697+lnk would be available 
for targeted epigenome editing, but further study is required on the expression level 
and the off-target effect.  
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To support the KLF4 targeting of KL-1 TALE-DME, DNA-binding assay 
of KL-1 TALE-DMEs was performed. A synthetic oligonucleotide containing KL-1 
target motif was radiolabeled and incubated with increased amounts of KL-1 TALE-
DME proteins. All three KL-1 TALE-DME proteins displayed protein-DNA 
complexes, which indicates that they efficiently bind to the target oligonucleotide 
(Fig. II-6). This data suggests that the KL-1 TALE module itself has strong DNA 
binding activity. In addition, to further verify the specific binding of the TALE 
module to the target sequence, DNA-binding competition assay was performed. The 
radiolabeled oligonucleotide substrate was incubated with KL-1 TALE-
DMEΔN677+lnk or KL-1 TALE-DMEΔN703+lnk proteins in the presence of the 
unlabeled oligonucleotide competitor (Fig. II-7). When KL-1 40M oligonucleotide 
was radiolabeled, and randomly designed 35-mer oligonucleotide (random 35M) 
was used as a competitor, KL-1 TALE-DMEΔN677+lnk strongly bound to the target 
KL-1 40M substrate (the left gel image of Fig. II-7a). However, the reverse 
experiment showed that the TALE-DME protein was dissociated with the 
radiolabeled random 35M substrate as the increase of the KL-1 40M competitor (the 
right gel image of Fig. II-7a). The same result was observed from the experiment 
with KL-1 TALE-DMEΔN703+lnk (Fig. II-7b), which implies that the KL-1 40M 









Figure. II-5. Targeted DNA demethylation of the KLF4 genomic region by 
TALE-DME. a) Analysis of DNA methylation levels for each cytosine by locus- 
specific bisulfite sequencing analysis. The transformants of HEK-293T cells were 
harvested 2 weeks after transfection with KL1 TALE-DMEΔN677+lnk, -
DMEΔN687+lnk, -DMEΔN697+lnk, and -DMEΔN703+lnk. Numbering indicates 
the cytosine position relative to the beginning of second intron of KLF4. KL1 
indicates the TALE binding region. Closed circle, methylated cytosine; open circle, 
unmethylated cytosine. b) A graph showing the ratios of DNA methylation level (y 
axis) for different positions relative to the beginning of the second KLF4 intron (x 






Figure. II-6. The KL-1 TALE-DME proteins efficiently bind to target 
oligonucleotide. The methylated oligonucleotide KL-1 40M including KL-1 
recognition site was incubated with increased amounts of purified DMEΔN677+lnk 
(a) or the KL-1 TALE-DME proteins (b-d). The free DNA substrate and the protein-





Figure. II-7. The KL-1 TALE-DME proteins preferentially bind to target 
oligonucleotide. Each radiolabeled oligonucleotide substrate was incubated with 
KL-1 TALE-DMEΔN677+lnk (a) or KL-1 TALE-DMEΔN703+lnk (b) in the 
presence of increased amounts of unlabeled competitor oligonucleotides, varied 
from 0 to 4-fold. DNA binding assay was carried out using radiolabeled KL-1 40M 
oligonucleotide with randomly designed 35-nt competitor (random 35M) (the left 
gel image of each panel), and the reverse experiment was performed using random 
radiolabeled 35M oligonucleotide with KL-1 40M competitor (the right gel image 





dCas9- and nCas9-DME activated RANKL expression  
 The above results show that the TALE-DME system is not as efficient as 
expected for activation of gene expression, despite induction of DNA demethylation. 
To improve the efficiency of the DME-based epigenome editing system, the 
CRISPR/Cas9 system, instead of TALEs, was used as a DNA binding module. 
Recently, the CRISPR/Cas9 system has been the most widely used system for 
genome editing. The CRISPR/Cas9 system has advantages of easy customization, 
sequence-specific DNA binding, and targeting multiple loci simultaneously in a host 
(Cong et al., 2013). The type II CRISPR/Cas9 system, the most well-studied system 
among the three types of CRISPRs, requires a relatively simple 5`-NGG PAM 
sequence at the adjacent 3’ end region of each target locus (Wang et al., 2016). 
 In this study, an all-in-one CRISPR/Cas9 system was used, which 
harbors two kinds of sgRNA and Cas9 expression cassettes (Fig. II-6a). Prior 
to epigenome editing using Cas9-DME, a Cas9 cleavage activity test was 
performed to examine whether Cas9 can recognize and cleave specific DNA 
sequence. Based on the previous report that RANKL expression is up-
regulated by sgRNA-guided DNA demethylation activity of dCas9-TET1CD 
in HEK-293T cells, RANKL was chosen as a target gene. Of the two sgRNAs 
that showed a significant increase in RANKL expression (Xu et al., 2016), the 
sgRNA targeting the adjacent region of the transcription initiation site of RANKL 
was selected for further investigations. For in vitro Cas9 cleavage assay, a linear 
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DNA fragment was prepared as a substrate. The recombinant plasmid containing the 
sgRNA sequence was digested with NdeI, and the Cas9 protein was purified from E. 
coli (Fig. II- 6b). Cas9 incubated with in vitro-transcribed sgRNA was able to cleave 
the target site, generating a digested DNA fragment, as expected (Fig. II-6c). Then, 
to confirm Cas9 activity in HEK-293T cells, the all-in-one plasmid containing Cas9 
and sgRNA targeting RANKL was transfected into HEK-293T cells, and the target 
region was amplified using gDNA isolated from GFP-positive cells 48 h after 
transfection. Cas9 generated the indels at the target region in vivo (Fig. II- 6d). These 
results indicated that sgRNA-guided Cas9 can efficiently recognize and cleave the 
target region of RANKL promoter.    
 The Cas9-epigenome editing system does not require DNA cleavage 
activity, but it needs DNA binding activity in an sgRNA-programmed manner. The 
cleavage-inactive form of Cas9, deadCas9 (dCas9) was generated by substitution of 
D10A and H840A. Subsequently, two engineered DME constructs, DMEΔ677+lnk 
and DMEΔ697+lnk, and TET1 CD were fused to dCas9 (Fig. II-7a). BbsI sites in 
the DME and TET1 CD fragments were removed by site-directed mutagenesis 
because the BbsI site was used for insertion of oligomers corresponding to sgRNA 
in the all-in-one CRISPR/Cas9 system (Fig. II-7a). These constructs were transfected 
into HEK-293T cells, and GFP positive cells were collected by FACS 48 h after 
transfection. dCas9 was used as a control, targeting the same locus. To detect off-
target activity of each construct, IFN β expression was measured because Chapter I 
demonstrated that DME expression in HEK-293T cells triggered IFN response. In 
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the cells expressing dCas9-DMEΔN677+lnk, there was no significant difference in 
the RANKL expression with highly increased IFN β expression (Fig. II-7b-c). 
However, the cells expressing dCas9-DMEΔN697+lnk exhibited slight increases in 
the RANKL and IFN-β expression levels (Fig. II-7b-c). Unexpectedly, an off-target 
effect occurred by dCas9-DMEΔN677+lnk, suggesting that DMEΔN677+lnk has its 
own DNA-binding activity (Mok et al., 2010, Mok et al., 2017). 
 The previous study reported a new approach of genome editing without 
double-strand DNA breaks. The cytidine deaminase conjugated with nCas9 (D10A) 
induced the direct conversion of cytidine to uridine, resulting in C to T (or G to A) 
substitution (Komor et al., 2016). The editing efficiency of APOBEC1-nCas9 in 
human cells showed a two- to six-fold increase relative to that of APOBEC1-dCas9, 
although indel frequencies of APOBEC1-nCas9 represented about 1.1% for the six 
tested loci (Komor et al., 2016). Based on the previous report, nCas9-
DMEΔN677+lnk, -DMEΔN697+lnk, and -TET1CD constructs were prepared and 
transfected into HEK-293T cells (Fig. II-8a). The RANKL expression level was 
highly increased in the cells expressing nCas9-DMEΔN697+lnk among the cells 
expressing nCas9-DMEΔ677+lnk, -DMEΔN697+lnk, and -TET1 CD (Fig. II-8b). 
Then, IFN β expression levels were measured to examine off-target activity of the 
nCas9 fusion proteins. The IFN β expression was highly upregulated in the cells 
expressing nCas9-DMEΔN677+lnk and slightly upregulated in the cells expressing 
nCas9-DMEΔN697+lnk and -TET1CD (Fig. II-8b). These results indicate that 
nCas9-DMEΔ677+lnk may induce the off-target effect through DNA binding 
activity of DME. Moreover, nCas9-DMEΔN697+lnk seems to minimize the off-
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target effect due to the loss of DNA binding activity of DME. Interestingly, 
DMEΔN697+lnk increased the transcription level of RANKL more than twice as 
much as TET1CD did (Fig. II-8b). It can be deduced that DNA demethylation 
efficiency of DMEΔN697+lnk is much higher than TET1CD. To investigate whether 
the increase in the RANKL expression is associated with targeted-DNA 









Figure. II-8. The Cas9 protein efficiently cleaves target DNA in vitro and in vivo. 
a) Schematic diagram of the all-in-one CRISPR/Cas9 system. RANKL sgRNA was 
driven by the U6 promoter, and GFP-Cas9 was driven by the constitutive CBh 
promoter. NLS, nuclear localization signal. b) SDS-PAGE gel image of purified Cas9 
protein from E. coli indicated with the arrow. The left lane represents the protein size 
marker. c) In vitro plasmid cleavage assay of the Cas9 protein. The target plasmid 
substrate was incubated with purified Cas9 protein and in vitro transcribed sgRNA 
in the presence of 5 mM MgCl2 for 2 h at 37°C. The relative sizes of input DNA and 
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cleaved DNA fragments are indicated to the right. d) In vivo cleavage assay of 
endogenous RANKL gene with the Cas9 protein. The HEK-293T cells were 
harvested 48 h after transfection with the construct described in (a), and GFP positive 
cells were collected. Representative Sanger sequencing results of the PCR amplicons 
are aligned to the reference genome sequence. TGG (blue) is the PAM sequence. The 
nucleotide insertion is shown in red letters, and the nucleotide deletions are shown 




Figure. II-9. Expression of RANKL was slightly upregulated by nCas9-DME. a) 
Schematic diagram of the all-in-one CRISPR/dCas9 system fused with 
DMEΔN677+lnk, DMEΔN697+lnk, or TET1 catalytic domain (CD). RANKL 
sgRNA was driven by the U6 promoter, and GFP-dCas9-DME was driven by the 
constitutive CBh promoter. NLS, nuclear localization signal. b-c) Relative 
expression levels of RANKL (b) and IFN β (c) from the HEK-293T cells transfected 
with dCas9-DMEs or dCas9-TET1 CD. The cells were harvested 48 h after 
transfection, and GFP-positive cells were collected. Results are shown after 




Fig. II-10. Expression of RANKL was upregulated by nCas9-DME. a) Schematic 
diagram of the all-in-one CRISPR/nCas9 system fused with DMEΔN677+lnk, 
DMEΔN697+lnk, or TET1 catalytic domain (CD). RANKL sgRNA was driven by 
the U6 promoter, and GFP-dCas9-DME was driven by the constitutive CBh promoter. 
NLS, nuclear localization signal. b) Relative expression levels of RANKL and IFN β 
from the HEK-293T cells transfected with nCas9-DMEs or nCas9-TET1 CD. The 
cells were harvested 48 h after transfection, and GFP-positive cells were collected. 
Results were shown after normalization to the nCas9 control. Error bars represent 




Genome editing has gained attention with the development of the DNA-
binding modules, ZF protein, TALEs, and the CRISPR/Cas9 system. Targeted 
manipulation of epigenetic marks, referred to as epigenome editing, can be achieved 
by the fusion of the DNA binding platforms to the catalytic domains of epigenetic 
modifiers including DNA methyltransferases, DNA demethylases, and histone-
modifying enzymes (Thakore et al., 2016). Given that DNA methylation is a stable 
epigenetic mark that regulates gene expression and can be inherited, the TALE-TET1 
and dCas9-TET1 fusion proteins were devised for targeted DNA demethylation and 
activation of silenced genes (Maeder et al., 2013c; Xu et al., 2016). However, a 
plant-specific DNA demethylase DME that catalyzes a direct excision of 5mC has 
not been reported for targeted DNA demethylation via fusion to DNA binding 
modules. In this chapter, DME fused with TALE or dCas9 induced the expression of 
specific target genes that were usually repressed by DNA hypermethylation.    
To activate the endogenous gene OCT4, TALE-DME fusion constructs 
targeting diverse regions were introduced into HEK-293T cells. Although the 
expression levels of OCT4 were slightly increased, DNA methylation level of the 
OCT4 promoter region was not altered by targeted DNA demethylation. Given that 
DNA binding activity of DME might contribute to the off-target effect, a series of 
N-terminal truncated DME constructs were used for KLF4-targeted DNA 
demethylation. The cells expressing KL-1 TALE-DMEΔN697+lnk showed 
decreased DNA methylation levels (Fig. II-5). The CRISPR/Cas9 system with higher 
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targeting efficiency was applied to targeted DNA demethylation. A dead Cas9 
(D10A/H840A) and a nicked Cas9, nCas9 (D10A), were used for RANKL-targeted 
DNA demethylation. The expression level of RANKL was more intensely activated 
by nCas9-DMEΔN697+lnk than by dCas9-DMEΔN697+lnk. Though it was 
expected that the dCas9 fusion protein would be efficient for activation of the 
RANKL expression, the nCas9 fusion protein was found to upregulate the expression 
of RANKL more efficiently than the dCas9 fusion protein. A hypothesis is proposed 
that the nickase activity of nCas9 would affect gene expression by coupling with 
DNA demethylation activity of DME. As gene silencing is associated with the 
heterochromatin (a tightly packed form of chromatin), both the nickase activity and 
DNA demethylation activity of the nCas9-DME protein can trigger the relaxation of 
condensed chromatin structure, resulting in the activation of the target gene. 
Although nCas9-DMEΔN697+lnk has the potential to activate the target gene, it has 
a limitation in that the indels are produced with a low ratio (Komor et al., 2016). 
In previous reports, dCas9-TET1CD could induce DNA demethylation at 
the targeted regulatory region and activate the associated genes (Xu et al., 2016; 
Morita et al., 2016). In order to recruit multiple copies of TET1CD, additional 
tagging systems such as the MS2 tagging system (Xu et al., 2016) and SunTag 
system (Morita et al., 2016) were utilized. The MS2 tagging system depends on the 
protein–RNA interaction, which allows the sgRNA containing MS2 binding stem-
loop sequence to recruit multiple MS2 coat proteins fused with TET1CD. The 
SunTag system is based on the antigen–antibody interaction that enables dCas9-
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fused SunTag harboring GCN4 peptide repeats to recruit multiple copies of anti-
GCN4 fused TET1CD. These tagging systems can maximize the efficiency of 
targeted DNA demethylation. It can be inferred that DNA demethylation activity of 
TET1CD is not efficient; because TET1 catalyzes the oxidation of 5mC to 5hmC and 
successive oxidation of 5hmC to 5fC and 5caC, the stepwise DNA demethylation by 
a single TET1CD may be inefficient. It can be presumed that multiple copies of 
TET1CD might be fused with dCas9 to induce effective DNA demethylation. If the 
additional tagging system that can directly remove 5mC is applied to dCas9 fused 
with DME, the efficiency of targeted DNA demethylation can be significantly 
increased. 
 
In this study, the most widely used Cas9, which is derived from 
Streptococcus pyogenes (SpCas9), was utilized. Among several Cas9 proteins, it is 
the largest, composed of 1368 amino acids. After dCas9 is fused with DME 
truncation series, the huge protein size (DMEΔN677+lnk, 673 aa; DMEΔN697+lnk, 
650 aa) can lead to improper protein folding. Using smaller SpCas9 orthologs from 
other species would overcome the protein-folding problem. CjCas9 derived from 
Campylobacter jejuni is the smallest Cas9, with 984 amino acids, and SaCas9 
derived from Staphylococcus aureus is composed of 1053 amino acids, which is 
smaller than SpCas9. These two types of Cas9 have potential for efficient and 
specific genome editing similar to SpCas9 (Kim et al., 2017; Ran et al., 2015).  
Although DME constructs fused with the DNA binding modules were 
shown to be expressed in HEK-293T cells. Several different trials failed in 
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attempting to increase the transfection efficiency. Intriguingly, the DME constructs 
showed relatively low transfection efficiency compared with TET1 CD constructs, 
though the size of engineered DME fragment is smaller than TET1 CD. The 
difference between DME and TET1 would arise from translation efficiency. 
Translation efficiencies of DME constructs would be relatively lower than that of 
TET1 CD in HEK-293T cells because the DNA sequence of DME fragment 
originated from Arabidopsis. Given that interspecific differences of codon usage are 
considered as an obstacle for efficient gene translation, the codon optimization 
would be able to obtain more GFP-positive cells expressing DME constructs and 
synthesize more TALE or dCas9-fused DME proteins in HEK-293T cells.  
In genome and epigenome editing systems, the off-target effect is 
considered as a major concern. Given that DMEΔN677+lnk did not increase the 
targeted gene expression, DNA binding activity of DME affected the off-target effect. 
To minimize off-target effects, DME constructs were engineered. The 
DMEΔN697+lnk activated the target gene more efficiently than TET1CD but 
slightly activated RANKL expression. It showed that the DMEΔN697+lnk construct 
would be adequate for an epigenome editing system. To further delicately engineer 
a DME construct for epigenome editing, DNA-binding residues of DME would be 
substituted without loss of DNA demethylase activity of DME. Unfortunately, the 
DME crystal structure has not yet been reported; thus, it is hard to change residues 
for DNA binding activity. Practically, a series of truncated DME at the N-terminus, 
DMEΔN703+lnk, DMEΔN713+lnk and DMEΔN1189+lnk, would be used to 
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minimize off-target effects.  
If the off-target effect of DME is reduced, it will be the most powerful 
epigenome editing tool for a wide range of fields such as cancer, imprinting disorders, 
metabolic disease, and target cell reprogramming. OCT4 and Nanog are essential 
regulator genes for induced pluripotent stem cells (iPSc) with promoter regions 
heavily methylated in somatic cells. These genes need autoregulation for maintaining 
pluripotent status in the pluripotent cell. The dCas9-DME fusion protein can 
efficiently activate the expression of OCT4 and Nanog simultaneously in a cell, 
which may result in iPSc. In addition, OCT4 and Nanog can be activated through the 
transgene-free transformation without endogenous mutation caused by the transgene 
since the dCas9 and DME proteins can be purified from E. coli.  
As diverse diseases and cancers are related with aberrant DNA methylation 
pattern, dCas9-DME fusion protein may be the best combination for clinical 
application of epigenome editing. However, many problems remain, such as the off-
target effect of the targeting module, transgene-free delivery method, and animal 
model study. To solve these problems, it will take a great deal of time and efforts by 
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ABSTRACT IN KOREAN 
후생유전이란 DNA의 염기서열 변화 없이 유전자의 발현이 조절
되는 것을 말한다. 진학 생물의 후생유전학적 기전 중 하나인 DNA 메틸
레이션은 DNA 메틸화효소에 의해 DNA염기 중 시토신의 5번째 탄소에 
메틸그룹이 결합되어 일어난다. 이를 메틸시토신(5mC) 이라고 부른다. 
DNA 메틸화는 동물 식물 모두에서 DNA 메틸화 효소에 의해 난다. 하지
만 DNA 탈메틸화는 동물 식물에서 다른 과정으로 일어난다. 동물에서의 
DNA 탈메틸화는 여려 효소에 의해 단계적으로 일어난다. 대표적으로 
Ten-eleven translocation (TET) 그룹에 의해 메틸시토신이 하이드로시메틸시
토신 (5hmC), 포밀시토신 (5fC), 카복시시토신 (5fca) 으로 산화되어 티민 
DNA 글라이코시레이즈에 의해서 제거된다. 또한 메틸시토신이 탈아미노 
효소에 의해 하이드로실메틸우라실 (5hmU)로 탈아미노 되어 우라실글라
이코시레이즈 의해 제거되는 복잡한 과정을 거친다. 반면, 식물은 동물에 
없는 DNA 탈메틸화 효소 DEMETER (DME) 그룹의 유전자에 의해 메틸
시토신이 직접 제거 되는 효과적인 DNA 탈메틸화 기작을 가지고 있다. 
본 연구에서는 동물에는 존재하지 않는 탈메틸화 효소인 식물의 DME를 
동물 세포에 발현시켜 세포에서 일어나는 변화를 관찰하였다. 동물 세포
에 발현된 DME는 메틸시토신을 제거하는 생화학적 활성을 유지하였고, 
세포분열의 감소, 세포분열주기의 정지, DNA 손상, 세포의 괴사를 유도
하였다. 또한 유전자 발현 프로파일링 결과 세포분열에 관여하는 유전자
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의 발현 변화, 열에 의해 유도되는 유전자의 발현 증가, 항바이러스에 관
여하는 유전자들의 발현이 증가하는 것을 확인 하였다. 특히 항바이러스
에 관여하는 유전자인 인터페론 베타가 DME가 발현하는 세포에서 발현
이 증가 하였다. 인터페론의 발현 증가는 DME에 의해 발현 증가가 유도
된 레트로트랜스포존에 의해 생긴 이중 가닥 RNA에 의해 유도되는 것
을 확인하였다. DME는 메틸시토신을 직접 제거하는 DNA 탈메틸화 효소
로 후성유전체 편집에 활용하기 좋은 유전자이다. 유전자편집기술에 사
용하는 TALE 도메인과 결합한 DME는 목표 위치의 DNA 메틸레이션을 
감소시켰다. 또한 CRISPR/nCas9 시스템에 DNA 결합 부분을 제거한 
DME를 결합하여 목표 위치의 하위에 있는 유전자의 발현을 유도하였다. 
이는 목표 이탈 효과도 없고, Tet1보다 목표유전자의 발현을 더 증가 시
켰다. 본 연구는 식물 유래의 유전자인 DME가 동물 세포에서 DNA 메
틸레션에 대한 연구에 활용 가능한 것을 증명하였다. 또한 향후 DNA 메
틸레이션에 의해 유발되는 사람의 질병 연구와 치료에 DME를 이용할 
수 있을 것으로 기대된다. 
 
